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REGULATION OF PPP1R15A (GADD34) AND PPP1R15B (CREP) MRNA EXPRESSION
AND LOCALIZATION IN THE UNFOLDED PROTEIN RESPONSE
Abstract
By Krithika Giresh
University of the Pacific
2022
The failure to balance protein synthesis, folding, and degradation in the endoplasmic
reticulum (ER) leads to the accumulation of unfolded proteins, leading to ER stress. Cells
respond to this stress by activating a response signaling pathway known as the Unfolded Protein
Response (UPR). One of the branches of the UPR induces the phosphorylation of eIF2α
(Eukaryotic Initiation Factor 2) to attenuate global protein synthesis, allowing for a chance to
clear misfolded and unfolded proteins. This phosphorylation of eIF2α is opposed by a
phosphatase, containing a catalytic subunit, Protein Phosphatase 1, and a scaffolding protein,
either GADD34 or CReP. Inhibition of eIF2α phosphatases has shown to promote survival in
cell types by prolonging the effects of the UPR. This research focuses on understanding the gene
expression patterns and localization of UPR specific genes with the presence of constant ER
stress. Zebrafish are an ideal model for this research because they are a good mimic of what
happens in humans and provide the ability to study gene expression and localization patterns at
different stages during ER stress and its recovery. The eIF2α phosphatases were shown to have a
protective effect on apoptosis when overexpressed in acute ER stress but were shown to have a
protective effect on apoptosis when knocked out in chronic ER stress. We sought to determine
the flow of gene expression of these phosphatases as well as other UPR specific genes, such as
BiP and CHOP, to determine the contradictory effects of acute versus chronic ER-stress induced
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apoptosis. We studied the changes in gene expression for these genes in zebrafish embryos by
isolating RNA and performing RT-qPCR after the induction of ER stress with pharmacological
drugs across multiple time points. There was increased gene upregulation and mRNA
localization to the fin epidermis and eye of GADD34, CReP, and BiP in acute ER stress from 2
hours to 6 hours, and these genes steadily declined in chronic ER stress from 24 hours to 48
hours. CHOP is a late-phase pro-apoptotic protein whose gene expression was upregulated in
chronic ER stress from 12 hours to 48 hours. This data was also supported by mRNA
localization studies performed by conducting whole mount in-situ hybridization on zebrafish
embryos treated with ER stress inducers for 4 hours and 24 hours. Our results indicate that all
UPR genes examined are affected by ER stress and their expression patterns are dependent on
the time length of ER stress induction, allowing us to get a more in-depth working model of this
branch of the UPR signaling pathway in zebrafish.
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CHAPTER 1: INTRODUCTION

The Endoplasmic Reticulum and Secretory Pathway
In all eukaryotic cells, the endoplasmic reticulum (ER) is the first compartment in the
secretory protein pathway. The ER is responsible for the synthesis, folding, modification, and
secretion of approximately one-third of all cellular proteins to their correct intracellular and
extracellular locations (Wang et al., 2014). In the ER, proteins fold into their correct
conformation and undergo post-translational modification, such as glycosylation,
phosphorylation, and formation of disulfide bridges (Schro ̈der et al., 2004). Protein folding and
trafficking is essential for proper cell function and survival.
Newly synthesized secretory or integral protein mRNAs are initially present in the
cytosol before ribosomes interact with them. These ribosomes target to the ER membrane via a
signal sequence within the amino terminus of the translated protein, known as the signal
recognition sequence, which interacts with the signal recognition particle (SRP) (Schwarz et al.,
2015). The complex is targeted to the ER where it docks on the SRP receptor; translation
continues, and the polypeptide enters the ER in an unfolded state through specialized ER
channels that form a pore and span the lipid bilayer (Schnell et al., 2003). A signal peptidase
then cleaves the signal sequence allowing the protein to enter the ER lumen. Inside the ER
lumen, protein folding and modifications are performed by chaperones and folding-enzymes.
Some of the modifications include N-glycosylation, disulfide bond formation and
oligomerization (Schwarz et al., 2015). Proteins that are correctly folded and modified to their
proper conformation are released from the chaperones and travel to the Golgi apparatus,
progressing through the secretory pathway. Proteins can then be sorted to be sent to different
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cellular compartments, recycled back to the ER (if they are chaperone proteins), or secreted into
the extracellular space (Schwarz et al., 2015; Alberts et al., 2002).
The ER facilitates protein-folding in an oxidizing and high calcium environment, which
allows for the formation of disulfide bonds and acts as a loading buffer for chaperone protein
function, respectively (Wang et al., 2016). Protein folding is usually the most error-prone stage
in gene expression and the efficiency of protein folding in the ER is greatly impacted by changes
in intracellular environments and extracellular stimuli. Variations in ER homeostasis can cause
the accumulation of misfolded and unfolded proteins (Wang et al., 2016), and this process can
lead to endoplasmic reticulum (ER) stress.
Endoplasmic Reticulum (ER) Stress
During protein folding in the ER, a fraction of proteins is misfolded and begin to
aggregate in the ER. When the accumulation of misfolded and unfolded proteins in the ER
exceeds the chaperone protein folding capacity, this leads to ER stress. ER stress can be caused
by a variety of intrinsic and extrinsic factors, such as increased levels of protein synthesis,
impaired ubiquitination and proteasomal degradation, deficient autophagy, energy deprivation,
excessive or limited nutrients, dysregulated calcium levels or redox homeostasis, inflammation,
and hypoxia (Wang et al., 2016). Since protein structure determines function, when proteins are
misfolded, they are unable to perform normal cellular functions. These proteins instead enter the
ER-associated degradation (ERAD) pathway, which is mediated by the proteasome to ensure that
the proteins that are misfolded do not enter the secretory pathway (Ruggiano et al., 2014).
ERAD is a signal transduction pathway that leads to increased chaperone activity, decreased
protein synthesis, and increased protein degradation (Thibault and Ng, 2012). There are several
connections between the activation of the ER stress response pathway, and various human
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diseases. Several neurodegenerative diseases caused by protein misfolding, such as Alzheimer’s
disease and Parkinson’s disease, activate ER stress response pathways. Furthermore, the
activation of ER stress response pathways is also observed in metabolic diseases, such as
diabetes, inflammatory bowel disease, alcoholic liver steatosis, and various cancers. The role of
ER stress and its response pathways in these diseases is an active area of research as potential
therapeutic targets are being investigated (Ryno et al., 2013).
The Unfolded Protein Response (UPR)
When ER stress occurs within cells and the normal protein folding process is not
restored, the hydrophobic residues on these proteins are exposed and are bound by chaperone
proteins. The accumulation of this protein complex leads to the activation of a stress response
pathway known as the Unfolded Protein Response (UPR) (Adams et al., 2019). The primary
function of the UPR is to increase ER folding machinery to properly fold the misfolded and
unfolded proteins.
The UPR is a multi-branched pathway (depicted in Figure 1) that has been proven to
sense and respond to ER stress. The UPR involves the activation of three branches that all
become active upon ER stress, centering on the activation of three proteins: inositol-requiring
enzyme 1α- X-box-binding protein 1 (IRE1α-XBP1), activating transcription factor 6 (ATF6),
and PKR-like ER kinase (PERK). The activation of all three pathways is dependent on the
detachment of a protein-folding chaperone, binding immunoglobulin protein (BiP), in response
to the increased load of unfolded proteins in the ER lumen. While the activation of both the
IRE1α-XBP1 and ATF6 promotes the transcription and activation of UPR target genes, such as
protein chaperones and components of the ERAD, the PERK-controlled pathway leads to the
general inhibition of protein translation.
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When the load of unfolded proteins in the ER increases, BiP detaches from IRE1α, a
trans-ER membrane bound protein, which contains both kinase and endoribonuclease activities.
The detachment leads to the trans-autophosphorylation of the IRE1α homodimer, which results
in the activation of its endoribonuclease activity, leading to the unconventional splicing of the
XBP1 mRNA (Sidrauski and Walter, 1997). The splicing of XBP1 mRNA alters the reading
frame for the translation of the XBP1 protein and leads to the synthesis of a transcription factor.
The XBP1 transcription factor translocates to the nucleus and activates UPR-targeted genes that
increase the cells’ capacity for protein folding, protein degradation, and transport pathways,
which can help to alleviate the stress of misfolded proteins within the ER (Adams et al., 2019).
IRE1α activation can also lead to other endoribonuclease activity, causing mRNA decay at the
ER membrane in a process known as IRE1α-dependent decay (RIDD) (Hollien and Weissman,
2006). In this process, mRNAs that encode transmembrane and secretory proteins are targeted
for degradation to reduce ER stress, therefore reducing the influx of protein load.
The second UPR pathway is the ATF6 pathway. The ATF6 protein is a trans-ER
membrane protein, and when BiP detaches in response to increased misfolded proteins and the
pathway is activated, ATF6 translocates to the Golgi apparatus. At the Golgi apparatus, it is
cleaved by Site-1 and Site-2 proteases to become an active transcription factor (Haze et al.,
1999). The ATF6 transcription factor translocates to the nucleus and can activate the
transcription of several genes involved in ER stress recovery, such as ER chaperones and ER
biogenesis proteins. ATF6 also induces the transcription of XBP1, which allows for the crosstalk
between ATF6 and the IRE1α stress pathways (Sharma et al., 2020; Yoshida et al., 2001).
The final UPR branch is the PERK branch, and the central pathway in this research
project. Upon BiP dissociation, PERK oligomerizes, autophosphorylates, and then
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phosphorylates the α subunit of eIF2 at serine 51. Phosphorylation of eIF2α inhibits the activity
of guanine nucleotide exchange factor, eIF2B, required for the formation of eukaryotic
translational preinitiation complexes (Hinnebusch, 2000; Pavitt et al., 2012). The inhibition of
eIF2B inhibits the initiation step of protein synthesis across the cell and decreases the amount of
mRNA entering the ER (Clemens, 1996). The decrease in protein production in the ER offers
the cell the opportunity to clear out misfolded and unfolded proteins from the ER (Brostrom and
Brodstrom, 1998). The phosphorylation of eIF2α activates a transcriptional activator, named
Activating Transcription Factor 4 (ATF4) (McQuistin et al., 2017). The two major downstream
targets of ATF4 are Growth Arrest and DNA Damage-inducible 34 (GADD34; also referred to
as PPP1R15A) and CCAAT/enhancer-binding protein “C/EBP'' homologous protein (CHOP).
The activity of GADD34 is a regulatory subunit of Protein Phosphatase I (PP1), while CHOP is a
transcription factor that controls expression of genes involved in apoptosis. Another scaffolding
subunit of PP1 is the constitutive repressor of eIF2α phosphorylation (CReP; also referred to as
PPP1R15B) (Harding et al., 2000). These protein phosphatases act to resume protein synthesis
upon ER stress recovery.
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Figure 1. Schematic Representation of the Unfolded Protein Response. Three branches of the
UPR (IRE1α, ATF6, and PERK) are activated in response to ER stress. IRE1α activation leads to
the splicing of the Xbp1 mRNA. PERK activation leads to the phosphorylation of eIF2α. ATF6
activation leads to the splicing of ATF6 to its active form. The downstream targets of all three
pathways lead to the upregulation of ER folding machinery and apoptotic proteins. Figure from
a future review article publication from the Weiser Lab.

PERK Pathway of the Unfolded Protein Response
eIF2α: Protein Synthesis, Kinases, Phosphorylation Effects
Phosphorylation of eIF2α by PERK leads to the decrease in protein synthesis due to the
inhibition of a guanine nucleotide exchange factor (GEF), eIF2B, resulting in a decrease in the
amount of mRNA being translated (Shrestha et al., 2012). The eIF2B complex consists of five
different subunits, two which participate in catalytic function and the other three which facilitate
regulation (Baird & Wek, 2012). During normal protein translation, the 40S ribosome
recognizes a start codon from the ternary complex formed between eIF2 with GTP and MettRNAi. This complex is loaded onto the 40S ribosome, forming the 43S ribosome. The 43S
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ribosome binds to the 5’ end of mRNA transcripts to begin protein translation. At the start
codon, eIF2-mediated GTP hydrolysis occurs, and eIF2-GDP is released. eIF2B then recycles
the eIF2-GDP to its active form, eIF2-GTP, which can be used for another translation initiation.
During ER stress, eIF2α is phosphorylated at serine 51 and forms a complex with eIF2B, causing
eIF2α to transform into a competitive inhibitor of the GEF, and increasing the affinity of eIF2 for
GDP. Consequently, there are reduced levels of active eIF2B and eIF2α, resulting in a decrease
in global protein synthesis (Hinnebusch, 2014).
Mammals express four different eIF2α kinases (depicted in Figure 2), each of which
monitor for different exogenous and endogenous stresses. The four kinases are GCN2
(EIF2AK4), which is induced in response to nutritional stresses and amino acid deprivation,
PKR-like endoplasmic reticulum kinase (PERK) (EIF2AK3/PEK), which is induced in response
to ER stress, HRI (EIF2AK1), which is activated by heme deprivation in red blood cells, and
protein kinase R (PKR) (EIF2AK2), which participates in an antiviral defense pathway involving
interferons (Baird & Wek, 2012). These kinases are critical and irregularities in any of these
kinases lead to pathologies in various organs.
Even though phosphorylation of eIF2α leads to the attenuation of global protein
synthesis, certain mRNAs that encode for stress-related proteins are selectively allowed to
upregulate and get translated (Reid et al., 2016). One such protein that becomes activated when
the PERK pathway is activated is ATF4. The ATF4 mRNA contains a short, upstream open
reading frame (uORFs) within its 5’ translated region (Andreev et al., 2015; Harding et al.,
2000). The upregulation of ATF4 promotes the synthesis of multiple pro-survival genes
(Harding et al., 2000).
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Figure 2. Schematic Representation of eIF2α Kinases. GCN2 activation, resulting from amino
acid deprivation, PKR activation, resulting from viral infection and dsRNA binding, HR1
activation, resulting from heme deprivation, and PERK activation, resulting from ER stress,
collectively phosphorylate eIF2α. The phosphorylation of eIF2α results in the global attenuation
of protein synthesis and the upregulation of pro-survival gene cascade through ATF4
activation. Figure from a future review article publication from the Weiser Lab.

Activating Transcription Factor 4 (ATF4) and Downstream Targets
With the activation of PERK (depicted in Figure 3), the phosphorylation of eIF2α leads to
the upregulation of ATF4. ATF4 translocates to the nucleus to activate UPR genes, which are
shown to be involved in autophagy, antioxidant response, amino acid biosynthesis and transport,
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increased protein chaperones, and the promotion of ERAD signaling pathway (Harding et al.,
2003; Han et al., 2013). ATF4 leads to the transcription of GADD34, which is a regulatory
subunit of PP1 and leads to the dephosphorylation of eIF2α to restore global protein synthesis.
ATF4 also promotes the transcription of CHOP, a pro-apoptotic transcription factor, by binding
to and activating the CHOP promoter (Fawcett et al., 1999; Harding et al., 2000; Ma et al., 2002;
Marciniak et al., 2004). CHOP expression is induced by stress and is required for ER stressinduced apoptosis during chronic ER stress. CHOP is found to mediate a later-phase apoptotic
pathway distinct from the cell death response mediated by p63 and puma (Pyati et al., 2011).
Because of the roles of ATF4 and CHOP, the PERK signaling pathway can promote both a prosurvival response (through ATF4) and an apoptotic response (through CHOP) in response to ER
stress.
Both ATF4 and CHOP mRNAs and proteins have short half-lives, implying that chronic
PERK activation is necessary to promote high levels of CHOP (Wang and Kaufman., 2014).
The human CHOP protein contains transcriptional activation and repression domains at its Nterminus and a C-terminal basic-leucine zipper (bZIP) domain, which contains a DNA-binding
region and a leucine zipper motif for dimerization (Oyadomari and Mari, 2004; Ron and
Habener, 1992; Ubeda, 1996). The bZIP domain allows CHOP to form heterodimers with other
C/EBPs and the CREB/ATF family, which is required in CHOP-induced apoptosis (Matsumoto
et al., 1996; Maytin et al., 2001), although the mechanism is not yet fully understood. CHOP
also plays a role in inducing the expression of GADD34 by binding to the GADD34 promoter
(Marciniak et al., 2004), allowing for the reversal of protein attenuation. Reversal of protein
attenuation prematurely can contribute further to ER stress and allows the cell to undergo CHOPmediated apoptosis. CHOP has been implied to deplete cells of glutathione, which is an
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intracellular scavenger of Reactive Oxygen Species (ROS) (McCullough et al., 2001), while
ERO1α, which is a direct target of CHOP, promotes oxidizing conditions in the ER and also
leads to increased ROS, causing protein misfolding and death (Marciniak et al., 2004). CHOP
has also been shown to lead to ER-stress induced apoptosis through inhibiting the transcription
of Bcl2, an anti-apoptotic protein, which causes the upregulation of Bim, a pro-apoptotic protein,
which promotes the translocation of Bax, a pro-apoptotic protein, from the cytosol to the
mitochondria. Bax targets CDK2 and CDK4, cyclin dependent kinases, for degradation, leading
to cell growth arrest (Berthet et al., 2006, McCullough et al., 2001, Wang et al., 2001).

Figure 3. Schematic Representation of the PERK pathway of the Unfolded Protein Response. In
the presence of ER stress, PERK is activated and leads to the phosphorylation of eIF2α, resulting
in the global attenuation of protein synthesis and the upregulation of pro-survival gene cascade
through ATF4 activation. ATF4 also leads to the activation of CHOP, which leads to the
upregulation of pro-apoptotic proteins with chronic ER stress. GADD34 and CReP, which are
two of the regulatory subunits of PP1, allow for the dephosphorylation of eIF2α, resulting in the
restoration of global protein synthesis.
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eIF2a Phosphatases
The activity of PERK is opposed by two eIF2α phosphatases containing Protein
Phosphatase 1 (PP1), acting as the catalytic subunit, and either of the two homologous
scaffolding/regulatory subunits, GADD34 or CReP (Connor et al., 2001; Jousse et al., 2003).
These protein phosphatases act to dephosphorylate eIF2α and allow for protein synthesis to
resume when ER stress is cleared, but the effects of the specific roles of these phosphatases and
their interactions in the protein synthesis process is not well understood.
Growth Arrest and DNA Damage-Inducible 34 (GADD34) Protein: Structure, Function,
and Role in ER Stress
GADD34 acts as a negative feedback inhibitor of UPR signaling by interacting with PP1
to dephosphorylate eIF2α (Novoa et al., 2001). GADD34 expression is typically induced by
DNA damage, growth factor deprivation, and other forms of cell stress (Zhan et al., 1994).
Specifically, to ER stress, GADD34 expression is induced through the activity of PERK. PERK
is activated, phosphorylates eIF2α, which leads to the upregulation of ATF4 leading to GADD34
induction (Novoa et al., 2001). GADD34 functions as a scaffolding protein, having the ability to
interact with both PP1 and eIF2α (Choy et al., 2015). The human GADD34 is a 674 amino acid
and 73.5 kDa (Brush et al., 2003). A conserved C-terminal KVRF PP1-binding motif (that binds
to hydrophobic RVxF-binding pocket on the surface of PP1), a RARA motif C-terminal to the
KVRF motif, and ΦΦ motifs within the structural domain of GADD34 are required for PP1
binding and targeting PP1 to the ER (Brush et al., 2003; Choy et al., 2015). eIF2α binds to
GADD34 at the central PEST domain (residues 241-513), and allows for stable eIF2α
recruitment (Choy et al., 2015). eIF2α binding to GADD34 is independent of PP1 binding,
meaning that their binding to GADD34 is not dependent on the other’s binding. Finally,
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GADD34’s ability to localize to the ER is determined by the N-terminal 180 amino acids (Brush
et al., 2003). A schematic illustrating the GADD34 structural domain is depicted in Figure 4.
GADD34 plays a role in the progression of early-stage UPR to late-stage UPR (Reid et
al., 2016). Early-stage UPR is marked by the degradation of misfolded/unfolded proteins and
translation attenuation during the first hour of ER stress. The late stage of UPR begins at around
4 hours post-ER stress and is marked by the enhancement of ER protein folding capacity through
the increase in chaperone protein synthesis (Reid et al., 2014). After 4 hours of ER-stress
induction, GADD34 allows for the return of mRNAs that were released from the ER during
early-stage UPR, therefore allowing for the progression of the UPR to late-stage (Reid et al.,
2016). Cells that lack GADD34 show elevated phosphorylated eIF2α for a longer period of time
with ER stress induction. eIF2α phosphorylation within these cells is shown to decline at a much
later time point than wild-type, due to the activation of other known GADD34-independent,
mechanisms, such as the elevation of phosphorylated AKT, which is an inhibitor of PERK (Reid
et al., 2016).
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Figure 4. Model Representation of the GADD34 Structural Domains. GADD34 is 674 amino
acids and 73.5 kDa. It contains a PP1 binding domain with a conserved C-terminal KVRF
domain (residues 555-558) (orange), C-terminal RARA motif (blue), and ΦΦ motifs (V564 and
H565). eIF2α binding is at the four, central PEST domains (residues 241-513) (yellow). ER
localization is determined by the N-terminal 180 amino acids (gray).

Constitutive Repressor of eIF2α Phosphorylation (CReP) Protein: Structure, Function, and
Role in ER Stress
CReP, another negative feedback inhibitor of UPR signaling that binds to PP1 to
dephosphorylate eIF2α. CReP differs from GADD34 in that it is present in unstressed cells,
whereas GADD34 is only present in stressed cells, and its primary function is regulating basal
levels of eIF2α phosphorylation in unstressed cells (Jousse et al., 2003). CReP is a 713 amino
acid, 79.2 kDa protein that recruits PP1 to dephosphorylate eIF2α, similar to GADD34. The
conserved COOH-terminal of CReP allows for interaction with PP1, by recruiting the G-actin
cofactor to allow for substrate-specific dephosphorylation (Chambers et al., 2015; Chen et al.,
2015). The N-terminal amino acids 1-140 of CReP contain an amphipathic α-helix, which
allows for CReP to localize to membranes and interact with phosphomimetic eIF2α (Kloft et al.,
2012). CReP contains the RVxF PP1-binding motif (amino acid residues 640-643) required for
the formation of the CReP–PP1 complex to dephosphorylate eIF2α (Rojas et al., 2015).
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Recruitment of eIF2α is encoded by the conserved residues 340-639 within the structure of CReP
(Hodgson et al., 2021). A schematic illustrating the CReP structural domain is depicted in
Figure 5.
Cells that lack CReP were shown to have higher levels of phosphorylation eIF2α, similar
to cells without GADD34, indicating that CReP is active in both stressed cells and unstressed
cells (Jousse et al., 2003). During ER stress, CReP has been shown to prevent the accumulation
of CHOP. When CReP was knocked out via RNAi targeting, the levels of CHOP seemed to
increase, which did not occur with GADD34 knockout (Jousse et al., 2003). It has been shown
that a lack of GADD34 resulted in increased translation or stabilization of the CReP mRNA,
allowing CReP to compensate for the lack of GADD34 in stressed cells (Reid et al., 2016).

Figure 5. Model Representation of the CReP Structural Domains. CReP is 713 amino acids and
79.2 kDa. It contains a RVxF PP1 binding domain (residues 640-643) to form the CReP-PP1
complex (orange). CReP’s COOH-terminal core allows CReP to interact with PP1 and recruit the
G-action cofactor (blue). N-terminal amino acids 1-140 (gray) are necessary for CReP to confer
vesicle association and induction. The recruitment of eIF2α is encoded by residues 340-639
(yellow).
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Mice Knockout Studies
Genetic knockout of GADD34 and CReP in mice have revealed the primary function of
these eIF2α phosphatases (Harding et al., 2009; Kojima et al., 2003; Nishio and Isobe, 2015).
The disruption of the GADD34 gene yields live mice that exhibit mild deficits in hemoglobin
synthesis and metabolic dysregulation (Kojima et al., 2003; Patterson et al., 2006; Harding et al.,
2009). Contrary to GADD34 knockout mice, mice with a loss of CReP gene yields more severe
phenotypes (Reid et al., 2016). The disruption of the CReP gene yields mice that were about half
the size of wild type at birth, pale in color, and failed to nurse, all of which died shortly after
birth with severe anemia (Harding et al., 2009). Double GADD34/CReP gene knockout mice
yield no detectable mouse embryos resulting from implantation defects (Harding et al., 2009;
Reid et al., 2016). These studies illustrate the distinct roles for GADD34 and CReP, with CReP
being uniquely crucial for survival.
UPR in Human Disease
The research being conducted to better understand the UPR is vital because of the many
implications that protein misfolding is a hallmark of several human diseases. ER stress has an
effect in the initiation and progression of various human diseases. Since prolonged UPR
activation has been shown to induce apoptosis, cells that experience chronic stress are more
susceptible to apoptosis, further leading to disease phenotypes. The UPR plays various roles in
the progression of neurodegenerative, metabolic, autoimmune, and inflammatory diseases as
well as different forms of cancers, and understanding the roles of eIF2α phosphatases in the
PERK branch of the UPR and other ER stress-related proteins will provide insight into the
development of novel disease therapeutics.
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Neurodegenerative Diseases
The major types of diseases that ER stress and UPR contribute to are neurodegenerative
diseases. The accumulation of misfolded and unfolded proteins within the neurons is a common
characteristic of neurodegenerative disease, therefore signifying the involvement of the UPR
during neurodegeneration. The accumulation of misfolded proteins leads to the activation of ER
stress-induced apoptosis and unlike skin or liver cells, neurons are unable to regenerate after celldeath, resulting in the loss of cognitive, motor, and neural functions, some of the key symptoms
seen in neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Aggregation of
proteins, such as neurofibrillary tangles (NFT), dystrophic neurites and neuropil threads, and βamyloid (Aβ) plaques, is a prominent hallmark of AD (Scheper et al., 2005). Markers specific to
UPR activation have been shown to be elevated in AD brain tissue compared to non-AD brain
tissue: BiP protein is increased in the hippocampus and temporal cortex, and p-PERK, p-IRE1α,
and p-eIF2α is increased within neurons (Scheper et al., 2005), confirming the involvement of
UPR pathways in AD. Parkinson’s Disease (PD) is characterized by the loss of dopaminergic
neurons in the substantia nigra along with the accumulation of α-synuclein in Lewy bodies. pPERK and p-eIF2α were shown to localize in the substantia nigra of PD brains compared to
control brains and were shown to associate with glial cytoplasmic inclusions containing αsynuclein, indicating the close association between UPR markers and the accumulation of αsynuclein (Cooper et al., 2006; Makioka et al., 2010; Stefanis et al., 2001). Although the UPR is
known to be involved in neurodegenerative diseases, specific mutations in UPR pathways that
cause neurodegeneration in humans have not yet been identified (Wang et al., 2016).
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Metabolic and Inflammatory Diseases
ER homeostasis has been shown to regulate glucose and lipid metabolism, therefore ER
stress and UPR pathways can contribute to various metabolic diseases, such as diabetes and nonalcoholic fatty liver disease (NAFLD) (Wang et al., 2016). IRE1α and its crosstalk with other
signaling pathways has been suggested to play crucial roles in glucose and lipid metabolism (Lee
and Ozcan, 2013). Cells with the loss of IRE1α are shown to be more responsive to insulin
compared to wild-type cells (Ozcan et al., 2004), resulting in a reduction in hepatic
gluconeogenesis and an improvement in glucose tolerance in obese and diabetic mice (BaillyMaitre et al., 2010; Mao et al., 2011). In addition, several animal studies have shown that the
PERK pathway is crucial in pancreatic β-cell function. Mice without the PERK gene developed
growth retardation and metabolic dysfunction, such as hyperglycemia, due to the loss of
pancreatic islet cells (Gao et al., 2012; Harding et al., 2001). Furthermore, in type 2 diabetes,
insulin resistance causes pancreatic β-cells to increase insulin synthesis and secretion, leading to
more protein production and making these cells more susceptible to ER-stress induced apoptosis.
In type 1 diabetes, inflammation induces ER stress in pancreatic β-cells, causing insulin
synthesis and secretion to become more difficult, therefore sensitizing cells to apoptosis
(Oyadomari et al., 2008). Finally, ATF6 has been shown to promote fatty liver disease (FLD)
during acute stress and reduce FLD during chronic stress in zebrafish models (Howarth et al.,
2014). ATF6 transcription is shown to be significantly upregulated in the liver and the deletion
of ATF6 has been shown to significantly reduce steatosis caused by alcohol. Genes promoting
glyceroneogenesis and fatty acid elongation were upregulated in zebrafish with ATF6
overexpression (Howarth et al., 2014).
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Cancer
The UPR is important in the field of oncology because its activation has been found in
various cancers: breast cancer (Fernandez et al, 2000), gastric cancer (Zhang et al., 2006; Scriven
et al., 2007), hepatocellular carcinoma (Shuda et al., 2003), pancreatic cancer (Scriven et al,
2008) and lung cancer (Uramoto et al, 2005). Cancers often develop and progress in stressful
microenvironment conditions such as hypoxia, nutrient deprivation, and poor vascularization,
resulting in ER stress and the activation of UPR. According to Scriven et al. (2009), a link has
been shown between UPR activation and a poor clinical outcome. High levels of BiP expression
correlated with increasing tumor growth in hepatocellular carcinoma (Shuda et al., 2003), poor
clinical outcome in breast cancer (Lee et al., 2006), high mortality rate in prostate cancer
(Daneshmand et al., 2007), and higher metastasis in gastric cancer (Zhang et al., 2006). One of
the UPR pathways studied extensively in its relation to cancer is the PERK pathway. Since the
PERK pathway of the UPR can promote either survival (through ATF4) or apoptosis (through
CHOP), the stage of the cancer determines the impact this pathway has on tumor progression.
The apoptotic role of the PERK pathway was shown to have an anti-proliferation effect in
mammary epithelial cells to help prevent mammary tumor formation (Sequeria et al., 2007). The
pro-survival function of the PERK pathway was shown to be utilized by mammary carcinoma
tumor cells to maintain redox homeostasis and prevent the activation of the oxidative DNA
damage checkpoint, facilitating tumor growth (Bobrovnikova-Marjo et al., 2010). In addition,
CHOP has been shown to be involved in tumorigenesis. In a mouse model of K-ras -driven
G12V

lung cancer, CHOP appears to control early stages of tumor progression by inducing apoptosis in
response to microenvironmental stress (Huber et al., 2013).
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Genetic Disorders
A homozygous missense mutation (R658C) in the PP1c binding site of CReP has been
found to cause an autosomal recessive condition leading to multisystem abnormalities. This
mutation results in reduced interaction between CReP and PP1c, increased eIF2α
phosphorylation, and sensitization of β-cells to apoptosis (Kernohan et al., 2015; Abdulkarim et
al., 2015). Patients with this mutation present with severe microcephaly, short stature,
hypoplastic brainstem and cord, delayed myelination and intellectual disability, pancreatic β-cell
failure and diabetes, and bone deformities (Kernohan et al., 2015; Abdulkarim et al., 2015).
Therapeutic Agents for Disease Phenotypes
Different approaches are being taken to treat diseases involving ER stress. Some
therapies target to reduce ER stress using small molecule chemical chaperones or proteinspecific chaperones, which help to prevent protein aggregation and facilitate protein folding by
stabilizing protein-folding intermediates (Wang et al., 2016). Other therapeutic approaches
target to induce ER stress and UPR activation to promote apoptotic pathways for cancer
treatment. However, inhibiting UPR activation may help to reduce cancerous cells' resistance to
chemotherapy (Wang and Kaufman, 2014). The potential for combining therapies to target the
UPR provides an approach to help combat different cancers, depending on their stages.
In metabolic disorders, mice without the PERK gene developed metabolic dysfunction,
therefore enhancing its expression and downstream targets improve the survival of the pancreatic
islet cells in mice models of diabetes. The pro-survival effect of ATF4 leads to increased
expression of GADD34 and CHOP, which helps to promote the recovery of translation of insulin
during ER stress (Yusta et al., 2006). In neurodegenerative diseases, inhibiting eIF2α
phosphatases with salubrinal is shown to have a protective effect (Saxena et al., 2009; Colla et
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al., 2012) due to providing the ER with time to clear accumulated misfolded proteins to prevent
apoptosis.
Benefits of Zebrafish as a Model Organism
Danio rerio (Zebrafish) serves as a model vertebrate organism throughout this research
and the embryos will be utilized to measure changes in gene expression and localization of UPRspecific transcripts with the induction of ER stress. Zebrafish offer many physical advantages
for studying gene expression and human disease phenotypes. They are relatively small in size
(about 2-3 cm), which allows for easy storage and manipulation, have a rapid generation time
(approximately 3 months), which entails for studies from early to late development, and has the
ability to produce a large number of externally fertilized embryos, making it possible to observe
normal or abnormal development of living zebrafish embryos without the sacrifice of the adult
zebrafish, like in the case with mice model organism (Lardelli, 2008). Zebrafish embryos
develop by cell division, meaning that early embryos are large enough to easily manipulate, for
example being injected with substances that regulate gene expression, such as mRNA and
morpholino antisense oligonucleotides (MO). Staining experiments, such as whole-mount in situ
hybridization, can be used throughout zebrafish embryogenesis due to the transparency of the
embryos (Jowett & Lettice, 1994).
Zebrafish, which are vertebrates, share a closer structural and physiological relationship
to humans than invertebrate models, with their genomes being similar in size (Lardelli, 2008).
Orthologues of most human genes can be found in zebrafish, which show similar patterns of
expression. Orthologous proteins are approximately 70% identical in their amino acid residue
sequence compared to humans (Lardelli, 2008). Zebrafish gene duplication events show that
duplicate orthologues of zebrafish genes exist, implying that the function of a single human gene
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can be found to be divided between two zebrafish orthologues (Lynch et al., 2000). This is
advantageous in a sense that a loss of function of one of the two zebrafish genes produces a
similar phenotype as a human disease phenotype, but both genes can also be easily abolished by
the injection of antisense morpholino oligonucleotides (Lardell, 2008).
The Zebrafish genome contains both GADD34 and CReP homologs, whereas other
model organisms such as Drosophila, C. elegans, and yeast either only contain one of the two
homologs or no homologs at all (Malzer et al., 2013; Rojas et al., 2014). Due to the presence of
the UPR specific genes that are the focus of this experiment, whole zebrafish embryos can be
utilized to measure changes in gene expression in response to ER stress to determine a model of
gene activation and coordination within the UPR pathway. Furthermore, the zebrafish epidermis
has been shown to induce high basal levels of ER stress and UPR signaling due to cells that are
rapidly growing and large amounts of proteins being synthesized to form the epidermal basement
membrane (Webb et al., 2007), which allows this tissue to be sensitized to ER stress induction
and provides a system in which the effects of manipulating various components of the ER stress
pathways can be observed and measured.
For these research studies, zebrafish embryos were grown to 24 hours post-fertilization
(hpf) before applying any pharmacological treatment. This time point was selected because most
major developmental patterning is complete by 24 hours, which allows for the assessment of
tissue-specific cell death (Pyati et al., 2007). Various drugs (Figures 6A-C) were utilized
throughout these experiments to induce ER stress in zebrafish embryos or inhibit parts of the
PERK pathway. Thapsigargin is a potent and highly specific ER stress inducing drug in
mammalian cells that works by disrupting calcium homeostasis by acting as a calcium pump
inhibitor (Thastrup et al., 1990). Tunicamycin induces ER stress in cell by inhibiting N-
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glycosylation of proteins, resulting in misfolded proteins, therefore blocking the proteins entry
through the secretory pathway, and resulting in their accumulation in the ER (Wu et al., 2018
and Guha et al., 2017). Salubrinal blocks the PERK branch of the UPR pathway by specifically
blocking the serine/threonine phosphatase-dependent dephosphorylation of eIF2α by inhibiting
the PP1 complexes that form with both GADD34 and CReP (Boyce et al., 2005).

Figure 6. Structures of Drugs Used to Induce ER Stress. A: Salubrinal inhibits GADD34 and
CReP function by blocking eIF2α complex formation. B: Tunicamycin inhibits N-glycosylation
of proteins. C: Thapsigargin inhibits calcium pumps and disrupts calcium homeostasis.

The ability of zebrafish to produce large clutches of embryos in a single round of mating
is useful in this research because of the ability to perform gene expression and localization
studies of several different genes of interest. The embryos are only needed for up to 72 hpf for
most experiments, allowing data to be collected and analyzed with many embryos in a relatively
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short period of time. Zebrafish are an extremely advantageous organism for the experiments,
compared to mice and fly models, due to the ability to look at the genes of interest and be able to
conduct several time-course analysis experiments.
Project Goals
A previous graduate student in the Weiser lab conducted several apoptosis assays with
GADD34 and CReP overexpression and knockdowns with the induction of ER stress. Her data
suggested that overexpression of GADD34 during acute ER stress, with 4 hours of ER stress
induction, which is via the CHOP-independent pathway, appeared to have a protective effect on
apoptosis, leading to decreased levels of apoptotic cells with GADD34 overexpression. She also
found that knockout of GADD34 had a protective effect on apoptosis during chronic ER stress,
with 24 hours of ER stress induction, which is via the CHOP-dependent pathway. Finally, the
knockout of both GADD34 and CReP appeared to have a protective effect at both the acute and
chronic stages of ER stress. These conclusions open several questions on what the expression
patterns of GADD34 and CReP are across multiple time points. Understanding the expression
patterns of these two genes can help us understand why there seems to be protective effects of
apoptosis with either gene overexpression or gene knockouts at different stages of ER stress
induction.
The primary goal of this project is to observe and understand the changes in the dynamic
gene expression pattern of UPR specific genes, specifically GADD34 and CReP, in zebrafish
embryos treated with ER stress inducers. Although GADD34 and CReP are known to be critical
regulators of UPR signaling and apoptosis in mammals, these genes have not been studied in
detail in zebrafish. Preliminary studies have shown that GADD34 mRNA increases rapidly and
remains elevated after ER-stress, while CReP transiently increases upon acute ER stress and
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declines below baseline after chronic ER stress. By taking a genetic approach (through
performing real-time quantitative PCR), this project seeks to understand how levels of GADD34
and CReP, as well as upstream and downstream UPR related genes, are regulated by ER stress.
Furthermore, determining the localization of these genes products (through RNA whole mount
in-situ hybridization) will help to verify the spatial-temporal expression pattern of these genes,
something that has never been done before. This set of experiments will also help confirm that
the zebrafish are a good model for the study of GADD34 and CReP proteins, by proving that
their expression patterns mimic what is seen in other model organisms. Together, these
experiments will help determine that GADD34 and CReP are dynamically expressed and are
critical regulators of the UPR signaling pathway.
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CHAPTER 2: MATERIALS AND METHODS

Fish Maintenance
Zebrafish were kept in 9.5-liter water tanks in an aquaneering, circulating system
maintained at 28℃. Males and females were kept in the same tanks and were placed on a
light/dark cycle for breeding. Fresh fish water was prepared in volumes of 20 gallons DI water
containing 4.5g Instant Ocean, 1.5g CaCl2, and 5g NaHCO3. The water was replaced once a
week to prevent waste accumulation. Fish were fed twice daily with tropical flakes and brine
shrimp.
Fish Breeding
Zebrafish breeding tanks with a divider were filled with fish water and males and females
from the same fish line were divided equally between 5 to 6 breeding tanks in the late afternoon,
1 hour after feeding. The males and females were separated overnight, and the divider was
removed the next morning and fish were allowed to spawn/breed for 20 to 40 minutes (till
embryos were present in the tank). Adult fish were returned to their regular tanks, and the
embryos were collected using a strainer and washed with 1X E3 embryo media (diluted from
50X E3: 14.5g NaCl, 0.66g KCl, 2.4g CaCl2, 4.08g MgCl, 1L MilliQ Water). Embryos were
placed in petri dishes and incubated at 28.5℃ for 24 hours.
Zebrafish Embryos Drug Treatments
24 hours post-fertilized (hpf) were treated with pronase (Sigma) for about 10 to 12
minutes to remove chorions, and then washed with 1L of 1X E3 embryo media. To a 24-well
plate, 5 dechorionated zebrafish embryos at 24 hpf were placed per well and 1X E3 media
solution was removed. 500µL of appropriate drug solution diluted in 1X E3 media was added to
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each well and the embryos were incubated at 28.5℃ for varying time points for gene expression
and RNA in-situ studies. Drugs were used at the following concentrations: 1µM thapsigargin in
E3 embryo media, 50µM salubrinal in E3 embryo media, and 2.5µg/mL tunicamycin in E3
embryo media. DMSO was used as a control.
Total RNA Isolation
RNA was isolated from drug-treated zebrafish embryos by washing the embryos several
times with sterile E3 embryo media. Embryo media was discarded and 500µL of TRI Reagent
(Sigma) was added and the embryos were homogenized by vigorous pipetting. An additional
500µL of the TRI reagent was added to the homogenized mixture and the sample was incubated
on ice for 15 minutes. Then 200µL of Chloroform (Sigma) was added and the sample was
shaken vigorously for 15 seconds and then incubated for 2 to 3 minutes at room temperature.
Sample was then centrifuged for 15 minutes at full speed (21130 rcf). The upper, aqueous phase
was carefully suspended in a clean, sterile Eppendorf tube. 1 volume of sterile isopropanol was
added to the RNA sample and mixed by pipetting 6 to 8 times. The sample was then incubated
on ice for 10 minutes and then centrifuged for 30 minutes at full speed (21130 rcf). The
supernatant was discarded, and the pellet was washed with 1mL for sterile 75% Ethanol. Sample
was then centrifuged for 5 minutes at full speed (21130 rcf), and the supernatant was discarded.
The pellet was then allowed to air dry for 5 to 7 minutes and then resuspended in 50µL of
nuclease-free water. The sample was incubated at 50℃ to 60℃ for 10 minutes to completely
resuspend the RNA pellet. RNA concentration was determined using a UV spectrophotometer,
and the RNA was stored at -80℃.
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DNase I Treatment and Reverse Transcriptase Reaction
The isolated, purified RNA was treated with DNase to remove genomic DNA. The
reaction was set up according to Table 1 below, with a total volume of 15 μL. The sample was
incubated at room temperature for 15 minutes, then 1.5µL of EDTA was added and the sample
was heated for 10 minutes at 65℃.
1.5µL of 50µM Oligo-dT primer and 1.5µL of 10mM RNA dNTP reagent was added to
the DNase I treated sample and the sample was heated for 5 minutes at 65℃. The sample was
subjected to reverse transcription, and was set up according to Table 2 below, with a total
volume of 30 μL. The sample was incubated at 50℃ for 10 minutes, then heated to 80℃ for 10
minutes to stop the reaction. The cDNA was stored at -20℃.

Table 1
DNase I Treatment Reaction Volumes
Reagent

Volume

RNA

1.5µg

Water

Up to 15µL

10X DNase I Buffer

1.5µL

DNase I Amp-Grade Enzyme

1.5µL
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Table 2
Reverse Transcription Reaction Volumes
Reagent

Volume

5X Superscript IV Buffer

6µL

100mM DTT

1.5µL

RNase Out

1.5µL

Superscript IV Enzyme

1.5µL

Real-Time Quantitative PCR Reaction
To determine the changes in gene expression, the cDNA was subjected to real-time
quantitative PCR (qPCR) for the following genes: eF1ɑ (control), PPP1R15a, PPP1R15b, ddit3,
and Hspa5 (primer sequences listed in Table 3). The reaction was set up according to the
volumes listed in Table 4 to a total volume of 20µL. Forward and reverse primers were diluted
to a concentration of 10µM. The samples were loaded into a 96-well plate and the reaction was
set up according to Table 5. The initial denaturation step was 30 seconds at 95℃. Then 40
cycles of the following were performed: denaturation step at 95℃ for 15 seconds, annealing and
extension step at 59℃ for 30 seconds, followed by a plate read step. After 40 cycles, the thermal
cycler was programmed to perform a melt-curve analysis from 65℃ to 95℃ with a 0.5℃
increment every 2 to 5 seconds. The final products were maintained at 4℃ after cycling and
were then stored at -20℃.
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Table 3
Sequence of Primers Used in RT-qPCR
Gene Name

Primer Sequence

Tm

PPP1R15a (GADD34) F

5’ TCGTCTGTCAGCTCCAGAAC 3’

62℃

PPP1R15a (GADD34) R

5’ GCGGATCTGCTCGCATAACT 3’

62℃

PPP1R15b (CReP) F

5’ TCGTCTGTCAGCTCCAGAAC 3’

62℃

PPP1R15b (CReP) R

5’ GCGGATCTGCTCGCATAACT 3’

62℃

Ddit3 (CHOP) F

5’ CACCTCATCCGGAGATCTCC 3’

64℃

Ddit3 (CHOP) R

5’ GACGCTGAGGAGCAGGATGA 3’

64℃

Hspa5 (BiP) F
Primer Set 1

5’ TCCCAGATCTTCTCCACTGC 3’

62℃

Hspa5 (BiP) R
Primer Set 1

5’ GTTGACGTCGATCTCGAAAGT 3’

62℃

Hspa5 (BiP) F
Primer Set 2

5’ GAGAATCGACAGCCGCAATG 3’

62℃

Hspa5 (BiP) R
Primer Set 2

5’ CCGCACTGCCGTACAGTTTG 3’

64℃

Elongation Factor eF1ɑ F

5’ CTGGAGGCCAGCTCAAACAT 3’

62℃

Elongation Factor eF1ɑ R

5’ TCAAGAAGAGTAGTACCGCTAGCATT 3’

74℃
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Table 4
Reaction Set Up for qPCR
Reagents

Volume

iTaq Universal SYBR Green Supermix (BioRad)

10µL

Forward Primer (variable according to gene)

1µL

Reverse Primer (variable according to gene)

1µL

DNA Template

2µL

RNase-free Water

6µL

Table 5
qPCR Conditions for Amplification
Temperature

Time

95℃

30 seconds

95℃

15 seconds

59℃

30 seconds

Plate Read
65℃ - 95℃ (0.5℃ increment)

2 to 3 seconds

10℃

Infinite
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Real-time Quantitative PCR Statistical Data Analysis
Statistical significance was estimated using a One-sample T test with IBM SPSS
Statistics version 28.0.1.1 (14). A P value of < 0.05 was considered statistically significant.
Bacterial Transformation
Competent E.coli cells (One Shot Top10) were thawed on ice for 10 minutes, then 1 to
2µL of plasmid DNA was added to 100µL of competent cells and gently stirred with a pipette tip
to mix. The mixture was incubated on ice for 30 minutes. The cells were then heat-shocked in a
42℃-water bath for 30 seconds and immediately transferred to ice for 1 minute. 900µL of
sterile LB Broth was added to the cells and incubated at 37℃ in a shaker incubator at 200 rpm
for 1 hour. 500µL of sterile LB Broth was added to 100µL of the transformed cells and the
mixture was plated onto pre-warmed agar plates containing 100µg/mL ampicillin, and plates
were incubated overnight at 37℃.
Midi Prep
An overnight bacterial culture was prepared using single colonies from bacterial
transformation to inoculate 50mL LB Broth containing 1000X carbenicillin in a 250mL
Erlenmeyer flask. Culture was incubated overnight at 37℃ in a shaker incubator at 200 rpm.
The plasmid DNA was isolated using the E.Z.N.A Ⓡ Plasmid Midi Kit Centrifugation protocol
(Omega Bio-tek).
Overnight cultures were transferred to a 50mL conical tube and centrifuged at 3,000 x g
for 10 minutes at 4℃, and the supernatant was discarded. 2.25mL of Solution 1/RNase A was
added, and the cells were resuspended. Then, 2.25mL of Solution II was added, and the conical
tube was gently inverted 8 to 10 times until a clear lysate was formed, with a 2-to-3-minute
incubation at room temperature. 3.2mL of Solution III was added, and the conical tube was

47

inverted until a white precipitate was formed, with a 2-to-3-minute incubation at room
temperature. The mixture was then centrifuged at 15,000 x g for 10 minutes at 23℃ to obtain a
compact pellet. The supernatant was immediately and carefully transferred to a clean 15mL
conical tube. 3.5mL of the supernatant was added to a HiBind DNA Midi Column Collection
Tube and centrifuged at 3,000 x g for 3 minutes, and the filtrate was discarded. This was
repeated till all the clear supernatant was transferred to the Column Collection tube. Then, 3mL
of HBC Buffer (diluted with 100% isopropanol) was added to the Column Collection tube and
centrifuged at 3,000 x g for 3 minutes, and the filtrate was discarded. Next, 3.5mL of DNA Wash
Buffer (diluted with 100% ethanol) was added to the Column Collection tube and centrifuged for
3,000 x g for 3 minutes, and the filtrate was discarded. The Column Collection tube underwent a
dry spin at 3,000 x g for 10 minutes before being transferred to a new, sterile 15mL centrifuge
tube. 0.5mL of Elution Buffer was added directly to the center of the Column and was incubated
for 3 minutes at room temperature. The sample was centrifuged at 3,000 x g for 5 minutes to
purify the DNA. DNA concentration was determined using a UV spectrophotometer and the
purified DNA was stored at -20℃.
Restriction Digest
Midi Prep DNA was digested using EcoR1 (produces sense mRNA) and Xho1 (produces
anti-sense mRNA) restriction enzyme. The vector map is depicted in Figure 7 below. The
reaction was prepared according to Table 6 below, with a total volume of 100µL, and the
reaction was incubated overnight at 37℃. The digest was confirmed by performing DNA gel
electrophoresis.
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Figure 7. Vector Map of pCS2+ MT.

Table 6
Reaction Set Up for Restriction Digestion of pCS2+ Vector
Contents

Amount

DNA

5 to 10µg

10X NEB Cutsmart Ⓡ Buffer

10µL

EcoR1 or Xho1

2µL

Water

To 100µL
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Phenol Chloroform Extraction
In the fume hood, 300µL of phenol and 30µL of 3M sodium acetate was added to the
100µL of digested DNA sample. The sample was gently inverted several times and allowed to
sit to initiate separation. The upper, aqueous layer was then transferred to a new, sterile tube,
while the organic, lower phase was discarded. 300µL of phenol was added to the aqueous
supernatant, and inverted several times, and allowed to sit to initiate separation. The upper,
aqueous layer was then transferred to a new, sterile tube and 300µL of Chloroform was added.
The sample was spun at full speed (21130 rcf) for 2 minutes. The upper, aqueous layer was
transferred to a new tube, and 2.5 volumes of ice-cold 100% Ethanol and 2µL of sterile glycogen
was added. The sample was frozen at -20℃ overnight.
The sample was centrifuged at full speed (21130 rcf) for 30 minutes. The supernatant
was removed and discarded, and 500µL of 70% Ethanol was added to wash the pellet. The
sample was centrifuged at full speed (21130 rcf) for 15 minutes. The supernatant was removed
and discarded, and the pellet was allowed to air dry for 5 to 7 minutes. The pellet was
resuspended in 30µL of RNase-free water. DNA concentration was determined using a UV
spectrophotometer, and the DNA was stored at -20℃.
cDNA Probes Transcription Reaction
The mRNA transcription reaction was prepared according to Table 7 below, with a total
volume of 20µL. Transcription reaction was performed at 37℃ for 2 hours, followed by the
addition of 2µL of DNase 1 Amp-grade enzyme, and the reaction was allowed to incubate for 30
minutes at 37℃. Then, 30µL of RNase-free water and 25µL of Lithium Chloride (LiCl) was
added to the sample and mixed by pipetting. The sample was stored at -20℃ for 1 hour. The
reaction was centrifuged at 4℃ for 15 minutes at full speed (21130 rcf). The supernatant was
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removed and discarded. 100µL of 70% ethanol was added to the sample and centrifuged for 5
minutes at full speed (21130 rcf). The supernatant was removed and discarded, and the pellet
was allowed to air dry for 5 to 7 minutes. The pellet was resuspended in 30µL of RNase-free
water. 1µL of the sample was mixed with 2µL of RNA dye and the mixture was run on an RNA
agarose gel. The remaining mRNA transcription sample was mixed with 160µL of hybridization
buffer with torula, and the cDNA probes were stored at -20℃.

Table 7
Reaction Set Up for cDNA Probe Transcription
Reagents

Volume

Linearized DNA (1 to 2µg)

Varies

10X DIG Labeling Mix

2µL

10X Transcription Buffer

2µL

RNase Out

1µL

T7 (sense probe) or SP6 (anti-sense probe) Polymerase

2µL

Nuclease-free water

To 20µL

RNA Gel Electrophoresis
The gel electrophoresis chamber, plate, and well-comb were filled with about 5mL 20%
SDS, about 1mL HCl, and filled with DI water, and was allowed to soak for 5 minutes. The
materials were thoroughly rinsed and dried. 1.5g of RNase-free agarose was dissolved
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completely in 100mL of freshly made 0.5X TBE to produce a 1.5% agarose gel. 5µL ethidium
bromide (10mg/mL) was added to the dissolved solution, and 25 to 50
mL was poured into gel caster. The solidified gel was placed in a gel electrophoresis chamber
filled with freshly made 0.5X TBE. 5µL of 1 kb ladder was loaded into the gel, along with 3µL
of cDNA probe sample (1µL of cDNA probe and 2µL of RNA dye). Samples were run at 180 to
200 volts for 10 to 15 minutes. The gel was then visualized using the UVP GelDoc-ItⓇe
Imaging system.
RNA In-Situ Hybridization Reaction
Drug treated zebrafish embryos were fixed for 4 hours to overnight at room temperature
in freshly made 4% Paraformaldehyde solution at pH 7.5. Paraformaldehyde was removed and
discarded in hazardous waste. The fixed embryos were washed 3 times with 1mL of 10X PBS.
The 10X PBS was removed and discarded. The embryos were stored in 1mL of 100% Methanol
(MeOH) at -20℃.
Rehydration:
The methanol was removed and discarded. The zebrafish embryos were rehydrated with
50% MeOH/ 50% 1X PBS-T for 5 minutes. The solution was removed and discarded, and the
sample was washed 4 times for 5 minutes with 1X PBS-T.
Proteinase K Digestion:
Proteinase K was diluted to 10µg/ml in a 10X PBS buffer and was added to the
rehydrated zebrafish embryos. The solution was incubated at room temperature for 20 to 30
minutes. The embryos were refixed at room temperature in freshly made 4% Paraformaldehyde
solution for 20 minutes. The paraformaldehyde was removed and discarded in hazardous waste,
and the fixed embryos were washed 4 times for 5 minutes in 1X PBS-T buffer.
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Prehybridization and Hybridization:
The 1X PBS-T buffer was removed and discarded. 500µL of hybridization mix with
torula was added to the zebrafish embryos. The sample was incubated in a 65℃-water bath for 2
to 5 hours.
The hybridization mix was removed and discarded. 200µL of hybridization mix with
appropriate cDNA probe (diluted 1:200) was added to the embryos. The sample was incubated
in a 65℃-water bath for 24 to 48 hours.
Wash:
The probe solution was removed and saved for later. The embryos were washed in a
65℃-water bath with pre-warmed reagents listed in Table 8 and were washed at room
temperature with reagents listed in Table 9.
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Table 8
Wash Reagents at 65℃ for RNA In-Situ Hybridization
Reagent

Time

100% Hybridization Mix (with 65% Formamide)

1 minute

75% Hybridization Mix/ 25% 2X SSC

15 minutes

50% Hybridization Mix/ 50% 2X SSC

15 minutes

25% Hybridization Mix/ 75% 2X SSC

15 minutes

100% 2X SSC

15 minutes

100% 0.2X SSC

30 minutes

100% 0.2X SSC

30 minutes

Table 9
Wash Reagents at Room Temperature for RNA In-Situ Hybridization
Reagent

Time

75% 0.2X SSC/ 25% 1X PBS-T

5 minutes

50% 0.2X SSC/ 50% 1X PBS-T

5 minutes

25% 0.2X SSC/ 75% 1X PBS-T

5 minutes

100% 1X PBS-T

5 minutes
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Block and Antibody Stain:
500µL of antibody block (2% goat serum, 2mg/mL in PBS) was added and incubated at
room temperature for 1 to 3 hours with gentle agitation. The block was removed and discarded.
500µL of antibody solution (diluted in 1:5000 in block) was added to the zebrafish embryos.
The solution was incubated overnight at 4℃ or 2 hours at room temperature. The solution was
washed quickly with 1X PBS-T. Then, the embryos were washed 6 times for 15 minutes with
1X PBS-T. The 1X PBS-T was removed and discarded. The embryos were then washed 3 times
for 5 minutes with freshly made alkaline phosphatase buffer without BCIP/NBT.
Development and Quench:
10mL of fresh alkaline phosphatase buffer with BCIP/NBT was made: 35µL BCIP and
45µL NBT in 10mL alkaline phosphatase buffer. 500µL of alkaline phosphatase buffer with
BCIP/NBT was added to zebrafish embryos. The embryos were stored in the dark until the
embryos turned purple. The reaction was stopped using 10X PBS. The embryos were rinsed 3
times with 10X PBS. The developed embryos were stored in MeOH at -20℃.
RNA In-Situ Hybridization Visualization
Stained embryos were imaged using the LEICA M80 Dissection Stereo Microscope. The
imaging software used to obtain the images of the embryos was the Leica Application Suite X
(LAS X) version 3.7.4.23463.
Cell Culture
Human cell lines HEK293T and Hep3B were obtained. The cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% Fetal Bovine Serum
(FBS) and 1% penicillin/streptomycin (10,000U penicillin/ 10,000µg/mL streptomycin). The
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cells were incubated at 37℃ in a humidified atmosphere of 5% CO2. Cells were seeded into 6well plates at 50% confluence.
Liquid Bacterial Transformation
Clones of zCReP wildtype-HA, zCReP 11A-HA, and zCReP 31A-HA previously
constructed in pcDNA 3.1 (+) vector were used. Competent E. coli cells (NEB5ɑ) were thawed
on ice for 10 minutes, then 2µL of plasmid DNA was added to 100µL of competent cells and
gently stirred with a pipette tip to mix. The mixture was incubated on ice for 30 minutes. The
cells were then heat-shocked in a 42℃-water bath for 30 seconds and immediately transferred to
ice for 1 minute. 500µL of sterile SOC media was added to the cells and incubated at 37℃ in a
shaker incubator at 200 rpm for 1 hour 15 minutes. The cells were added to 5mL of sterile LB
Broth supplemented with 1000X carbenicillin. The cells were incubated overnight at 37℃ in a
shaker incubator at 200 rpm.
Mini Prep
The plasmid DNA from the liquid bacterial culture was isolated using the QIAprepⓇ
Miniprep Kit.
Using the Miniprep protocol, 1.5mL of the overnight culture was transferred to a
microcentrifuge tube and centrifuged at 18,000 x g for 10 minutes. The supernatant was
removed and discarded, and this was repeated until all the overnight culture was transferred to
the microcentrifuge tube and centrifuged. The bacterial pellet was resuspended in 250µL in
Buffer P1, supplemented with RNase A (100µg/mL). The pellet was thoroughly resuspended in
the buffer, ensuring that no cell clumps are visible. 250µL of Buffer P2 was added to the
mixture, and the tube was gently inverted 4 to 6 times until a clear precipitate was formed, with a
2-minute incubation at room temperature. 350µL of Buffer N3 was added to the tube and the
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tube was inverted 4 to 6 times until a white precipitate was formed. The mixture was centrifuged
at 18,000 x g for 10 minutes to obtain a compact white pellet. 800µL of the supernatant was
carefully removed and transferred to the QIAprep 2.0 Spin Column and the column was
centrifuged at 18,000 x g for 1 minute. The flowthrough was discarded. 750µL of Buffer PE
(diluted with 100% ethanol) was added to the Spin Column and centrifuged at 18,000 x g for 1
minute. The flowthrough was discarded, and the Spin Column was centrifuged at 18,000 x g for
1 minute. The Spin Column was transferred to a clean microcentrifuge tube. 50µL of Buffer EB
was added to the center of the QIAprep Spin Column and was incubated for 1 minute at room
temperature. The sample was centrifuged at 18,000 x g for 1 minute to collect purified DNA.
DNA concentration was determined using a UV spectrophotometer and the purified DNA was
stored at -20℃.
Lipofectamine 3000 Transfection Protocol and Drug Treatments
At 60% to 70% cell confluence, cells were subjected to gene transfection using the
Lipofectamine 3000 kit from ThermoFisher. A DNA-lipid complex was prepared. In one, sterile
Eppendorf tube, 125µL of warmed Opti-MEM and 5µL of Lipofectamine 3000 reagent was
added and mixed by pipetting 6 to 10 times. In another, sterile Eppendorf tube, 125µL of
warmed Opti-MEM, 5µL of P3000 reagent, and 0.5 to 5µg/mL of DNA was added and mixed by
pipetting 6 to 10 times. Both of these mixtures were combined at a 1:1 ratio and incubated for 10
to 15 minutes at room temperature. The DNA-lipid complex was added to the seeded cells in the
6-well plate drop by drop. The cells were incubated for 24 hours at 37℃.
After the cells were incubated with the DNA-lipid complex for 24 hours, they were
subjected to drug treatments. 3µL of appropriate drug solutions were added to the cells drop by
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drop and incubated at 37℃ for 4 hours and 24 hours. Drugs were used at the following
concentrations: 50µM rotenone and 20µM bleomycin. DMSO was used as a control.
Protein Extraction
Cell media was aspirated from the 6-well cell plates, and cells were washed with 3mL of
1X PBS, followed by aspiration. 500µL of RIPA buffer (150mM NaCl, 50mM Tris, 1mM
EDTA, 1% NP-40, at pH 7.5) supplemented with 0.1% SDS and 45µL of Mammalian Protease
Inhibitor was added to each cell well. The cells were resuspended in the buffer by pipetting up
and down several times, avoiding the formation of bubbles. The solution was transferred into a
clean, sterile Eppendorf tube and was centrifuged at full speed (21130 rcf) for 15 minutes. The
supernatant was carefully removed into a clean, sterile tube, avoiding the cell pellet. The final
product was stored at -80℃.
SDS-PAGE
10% Resolving Gel (preparation listed in Table 10 below) and 6% Stacking Gel
(preparation listed in Table 11 below) were prepared with final volumes of 7.5mL and 5.0mL,
respectively.
10µL of protein extraction was mixed with 10µL of 2x Laemmli Sample Buffer,
supplemented with 𝛃-mercaptoethanol, and heated at 95℃ for 3 to 5 minutes. 10µL of
PageRuler Pre-Stained Protein Ladder was loaded into the gel, along with 20µL of the protein
sample. Gel was placed in the gel electrophoresis chamber filled with 1X TGS Buffer. Samples
were run at 250 amps for 3 to 4 hours.
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Table 10
Preparation of 10% Resolving Gel for SDS-PAGE
Reagent

Volume

30:0.8% w/v Acrylamide:Bisacrylamide

2.5mL

1.0 M Tris-Cl at pH 8.8

3mL

20% SDS

38µL

Double Distilled Water

1.9mL

10 % Ammonium Persulfate (APS)

36µL

Tetramethylethylenediamine (TEMED)

5µL

Table 11
Preparation of 6% Stacking Gel for SDS-PAGE
Reagent

Volume

30:0.8% w/v Acrylamide:Bisacrylamide

1mL

1.0 M Tris-Cl at pH 6.8

630µL

20% SDS

25µL

Double Distilled Water

3.6mL

10 % Ammonium Persulfate (APS)

25µL

Tetramethylethylenediamine (TEMED)

5µL
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Western Blot Transfer
After the SDS-PAGE gel finished running, it was soaked in 1X TG Buffer. The PVDF
membrane was soaked in 100% methanol. The Western Blot transfer cassette was set up and the
gel apparatus was filled with 1X TG Buffer. The transfer was run at 250 amps for 1 to 1.5 hours.
After the completion of the transfer, the PVDF membrane was soaked in a Blocking Buffer (5%
dry-powdered milk dissolved in 1X PBS-T Buffer). The membrane was blocked overnight at
4℃.
Western Blot Visualization and Analysis
The blocking buffer was discarded from the membrane. 2mL of monoclonal mouse antiHA antibody (1:1000) dissolved in the Blocking Buffer was added to the membrane and
incubated with shaking for 1 hour. The membrane was washed three times for 10 minutes with
1X PBS-T. 5mL of polyclonal goat anti-mouse antibody, HRP (1:5000) dissolved in the
Blocking Buffer was added to the membrane and incubated with shaking for 1 hour. The
membrane was washed three times for 10 minutes with 1X PBS-T. The membrane was
incubated for 2 minutes with 5mL of Immobilon Crescendo Western HRP substrate. It was then
visualized using the BioRadⓇ ChemiDoc XRS+ Imaging System.
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CHAPTER 3: RESULTS

Studying the Changes in Gene Expression of UPR-Specific Genes
To better understand the signaling of the PERK branch of the UPR, and the roles of
eIF2α phosphatases, we sought to determine the changes in gene expression of several targets:
GADD34 and CReP, two eIF2α phosphatases that are shown to inhibit the PERK branch of the
UPR; CHOP, a pro-apoptotic protein that is a downstream target of the PERK signaling
pathway; and BiP, a heat-shock protein located in the lumen of the ER that is also a downstream
target of all three branches of the UPR signaling pathway. These genes were studied by inducing
ER stress through pharmacological treatment using drugs such as Salubrinal, Tunicamycin, and
Thapsigargin (Figure 6A-C). Salubrinal is an eIF2α phosphatase inhibitor that blocks GADD34
and CReP function, however its mechanism of action is not fully understood (Boyce et al.,
2005). Tunicamycin induces ER stress in cells by inhibiting N-glycosylation of proteins,
resulting in an increase of misfolded proteins (Wu et al., 2018 and Guha et al., 2017).
Thapsigargin is a potent ER stress inducer that works by disrupting calcium homeostasis by
acting as a calcium pump inhibitor (Thastrup et al., 1990).
To study the genes, forward and reverse primers were designed against the zebrafish
homologues of the GADD34 (PPP1R15a), CReP (PPP1R15b), two CHOP (Ddit3), and two BiP
(Hspa5) genes (primer sequences listed in Table 3). The primers were designed to have a
melting temperature between 60℃ - 64℃ and having a %GC of greater than or equal to 50%. A
2% agarose gel was run with the cDNA amplified using these primers to check for primer
efficiency (Figure 8). The gel confirmed the upregulation of only the target gene for the primers
designed for GADD34, CReP, CHOP (with only one primer set), BiP (with both the primer sets),
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and eF1α (a previously published primer) due to the presence of only band. Any lanes with
multiple bands (lane 4) resulted in the primer not being used for further analysis.

Figure 8. RT-qPCR Using Primers Designed to Amplify the Targeted Genes in Zebrafish
Embryos. 24 hpf embryos were treated for 4 hours with thapsigargin or DMSO (control), then
RNA was isolated for cDNA synthesis, and qPCR was performed to amplify the target genes.
Genes were run on a 2% agarose gel. Lane 1: 50bp ladder. Lane 2: BiP gene with primer set 1.
Lane 3: BiP gene with primer set 2. Lane 4: CHOP gene with primer set 1. Lane 5: CHOP gene
with primer set 2. Lane 6: GADD34 gene. Lane 7: CReP gene. Lane 8: eF1α gene.

Changes in Gene Expression of GADD34 with ER Stress Inducers and Salubrinal
To better understand the regulation of the PERK branch of the UPR, we sought to
examine and observe the changes in gene expression of GADD34. For these experiments,
zebrafish embryos were raised to 24 hpf and treated for various time-points (1, 2, 3, 4, 5, 6, 8, 10,
12, 20, 24, 36, and 48 hours) with Salubrinal [50µM], Tunicamycin [2.5µg/mL], and
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Thapsigargin [1µM] (controls were treated with DMSO in E3 embryos media). After treatment,
RNA was isolated from the zebrafish embryos, and RT-qPCR analysis was performed.
With Salubrinal treatment, GADD34 expression does not change much from the baseline
activity from the first hour of treatment (Figure 9A). The gene expression of GADD34 remains
at baseline or has a positive increase by 0.5x fold-change compared to baseline. This data
suggests that Salubrinal inhibits GADD34 expression, which can therefore result in the decrease
of eIF2α complex formation. The results obtained with Salubrinal treatment are preliminary
because for Salubrinal to have an effect there must be in presence of ER stress induction.
Further work must be conducted to determine the effects of Salubrinal on GADD34 gene
expression changes. With Tunicamycin treatment, GADD34 expression was shown to
significantly upregulate after 4 hours of drug treatment and decline steadily from 6 hours to 48
hours of treatment, back to baseline of 1x fold-change (Figure 9B). This data suggests that as
Tunicamycin is inducing ER stress by increasing the number of misfolded proteins in the ER, it
results in the activation of the early-phase UPR pathway, leading to the increase of the
expression of GADD34 after acute ER stress. With Thapsigargin treatment, GADD34
expression was shown to significantly upregulate after 4 hours of drug treatment, similar to
Tunicamycin, and decline steadily from 6 hours to 48 hours of treatment (Figure 9C). At the
later time points, with chronic ER stress, GADD34 expression levels downregulate significantly
below baseline. This data suggests that GADD34 expression does not change with Salubrinal
treatment, upregulates at about 4 hours with acute ER stress with both pharmacological ER stress
inducers, and downregulates significantly with chronic ER stress (Figure 9D).
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Figure 9. Changes in GADD34 Expression with ER Stress Induction. Zebrafish was treated with
Salubrinal, Tunicamycin, and Thapsigargin (controls were treated with DMSO in E3 embryos
media) for 1, 2, 3, 4, 5, 6, 8, 10, 12, 20, 24, 36, and 48 hours, starting at 24 hpf. RNA was
isolated and purified, and RT-qPCR was performed. dCt values were calculated by normalization
to eF1α, and ddCt values were calculated by normalization to DMSO. Fold changes (2-ddCt) were
calculated based on mean ddCt values. Error bars represent the standard error of the ddCt mean.
Statistical significance was determined using a one-sample t-test, with significant differences
indicated (*) when p<0.05. A. GADD34 expression with Salubrinal [50μM] treatment. B.
GADD34 expression with Tunicamycin [2.5µg/mL] treatment. C. GADD34 expression with
Thapsigargin [1µM] treatment. D. Combination of GADD34 expression with all three drug
treatments.

Changes in Gene Expression of CReP with ER Stress Inducers and Salubrinal
In addition to studying the expression of GADD34 to better understand the PERK branch
of the UPR, we sought to examine and observe the expression of PPP1R15b (CReP), a second
eIF2α phosphatase that functions as the regulatory subunit of PP1. CReP expression
experiments were maintained the same as those of the expression experiments of GADD34.
With Salubrinal treatment, CReP expression does not change from the baseline activity
from the first hour of treatment, till the expression upregulates at about 8 hours of treatment to
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about 2.5x fold-change (Figure 10A). The expression of CReP declines back to baseline
between 10 hours to 24 hours of treatment and downregulates below baseline with chronic ER
stress (36 and 48 hours). This data suggests that Salubrinal may have a better effect of inhibiting
CReP expression during acute time-points compared to chronic time-points due to CReP being
inhibited with Salubrinal treatment during the earlier time-points and the inhibition not being
present during the later time-points. Alluding to earlier, the Salubrinal data do not lead to clear
conclusions since these treatments were not done with ER stress induction. To better understand
the role of Salubrinal on gene expression, co-treatments with Salubrinal and an ER stress inducer
must be conducted. With Tunicamycin treatment, CReP expression was shown to significantly
upregulate at about 8 hours of drug treatment, and steadily downregulate from 10 hours to 48
hours of treatment, dropping below baseline expression (Figure 10B). This data suggests that
Tunicamycin's effect of ER stress induction results in the activation of the UPR pathway
between early-phase and late-phase. The expression of CReP seems to upregulate after acute ER
stress and decline during chronic ER stress. With Thapsigargin treatment, CReP expression was
shown to significantly upregulate after 4 hours of drug treatment and upregulated steadily till
about 8 hours of treatment (Figure 10C). After 8 hours of treatment, the expression of CReP
significantly downregulates till baseline expression. This data suggests that Thapsigargin
upregulates CReP expression during acute ER stress and declines during chronic ER stress.
Together, the data from these experiments suggests that the expression of CReP is upregulated
with acute ER stress with both pharmacological ER stress inducers, and downregulates with
chronic, continued ER stress (Figure 10D).
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Figure 10. Changes in CReP Expression with ER Stress Induction. Zebrafish was treated with
Salubrinal, Tunicamycin, and Thapsigargin (controls were treated with DMSO in E3 embryos
media) for 1, 2, 3, 4, 5, 6, 8, 10, 12, 20, 24, 36, and 48 hours, starting at 24 hpf. RNA was
isolated and purified, and RT-qPCR was performed. dCt values were calculated by normalization
to eF1α, and ddCt values were calculated by normalization to DMSO. Fold changes (2-ddCt) were
calculated based on mean ddCt values. Error bars represent the standard error of the ddCt mean.
Statistical significance was determined using a one-sample t-test, with significant differences
indicated (*) when p<0.05. A. CReP expression with Salubrinal [50μM] treatment. B. CReP
expression with Tunicamycin [2.5µg/mL] treatment. C. CReP expression with Thapsigargin
[1µM] treatment. D. Combination of CReP expression with all three drug treatments.

Changes in Gene Expression of CHOP with ER Stress Inducers and Salubrinal
To better understand the UPR profile and UPR activation, we sought to observe the
changes of CHOP, a pro-apoptotic protein that is shown to be involved in late-phase UPR in
mammalian organisms. The experimental techniques used to analyze expression of this gene
were similar to that of GADD34 and CReP, as mentioned previously. While this research study
is heavily focused on the eIF2α phosphatase protein activation, it is necessary to look at other

66

genes that are a part of the UPR pathway to gain a clear understanding of the dynamic expression
of the pathway signaling.
With Salubrinal treatment, CHOP expression does not upregulate, and remains below
baseline to a point where the fold changes are not significant and cannot be detected (Figure
11A) of about -0.76x fold-change. There is not much change in the expression levels of CHOP
with Salubrinal treatment. It can be observed that Salubrinal does not influence CHOP
expression due to the absence of ER stress induction, therefore the early and late-phase UPR
pathways have not been activated, and ATF4 did not lead to the activation of the CHOP protein.
With Tunicamycin treatment, CHOP expression was shown to begin to significantly upregulate
at about 5 hours of treatment to about 4.89x fold-change (Figure 11B). During chronic ER
stress, the levels of CHOP begin to drop slightly from the highest expression, 4.89x fold-change
to 3.18x fold-change. CHOP levels continue to be upregulated above baseline levels during
chronic ER stress. This suggests that ER stress induction does not upregulate CHOP expression
at the acute stage, but upregulates, and continues to keep levels above baseline during chronic
ER stress. With Thapsigargin treatment, CHOP expression was shown to significantly
upregulated at 3 hours of drug treatment to about 3.92x fold-change and continues to upregulate
at 4 hours of drug treatment to about 4.32x fold-change (Figure 11C). After 5 hours, the
expression declines slightly to about 3.89x fold-change and remains at those levels of foldchange through the entire duration of ER stress induction with Thapsigargin. This data suggests
that Thapsigargin upregulates CHOP expression between acute and chronic, and the expression
remains elevated at the later time-points. Together, the data from this set of experiments
suggests that CHOP expression is not affected by Salubrinal treatment or that Salubrinal
represses the expression of CHOP overall, but CHOP expression increases in expression with
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Tunicamycin and Thapsigargin treatment after acute ER stress (Figure 11D). This data fits the
UPR profiling of CHOP being a late-phase UPR protein and is activated with ongoing ER stress.

Figure 11. Changes in CHOP Expression with ER Stress Induction. Zebrafish was treated with
Salubrinal, Tunicamycin, and Thapsigargin (controls were treated with DMSO in E3 embryos
media) for 1, 2, 3, 4, 5, 6, 8, 10, 12, 20, 24, 36, and 48 hours, starting at 24 hpf. RNA was
isolated and purified, and RT-qPCR was performed. dCt values were calculated by normalization
to eF1α, and ddCt values were calculated by normalization to DMSO. Fold changes (2-ddCt) were
calculated based on mean ddCt values. Error bars represent the standard error of the ddCt mean.
Statistical significance was determined using a one-sample t-test, with significant differences
indicated (*) when p<0.05. A. CHOP expression with Salubrinal [50μM] treatment. B. CHOP
expression with Tunicamycin [2.5µg/mL] treatment. C. CHOP expression with Thapsigargin
[1µM] treatment. D. Combination of CHOP expression with all three drug treatments.

Changes in Gene Expression of BiP with ER Stress Inducers and Salubrinal
The primary target that is shown to upregulate in mammalian cells with ER stress
induction is the hspa5 (BiP) chaperone protein. BiP is the protein that primarily keeps the
branches of the UPR pathway in their active state by binding to IRE1a, PERK, and ATF6. At
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the early stages of ER stress, BiP unbinds from the transmembrane proteins, in turn, activating
the three branches of the UPR. To better understand the expression profile of the UPR with
zebrafish, we sought to observe the changes of BiP; the experimental techniques used for the
analysis of this gene were similar to that of GADD34, CReP, and CHOP, as mentioned
previously. In order to study the BiP gene, two primers (distinguished as BiP-1 and BiP-2) were
designed, one closer to the 5’ end of the gene, and the other on the 3’ end of the gene (primer
sequences listed in Table 3).
With Salubrinal treatment, BiP expression with primer set 1 upregulates after 2 hours of
treatment to 1.77x fold-change and continues to upregulate further to its highest expression
levels after 5 hours of treatment to 2.39x fold-change. Then, it slowly declines in expression till
about 36 hours to 1.03x fold-change, right back to baseline (Figure 12A). BiP expression with
primer set 2 has a similar expression pattern as BiP with primer set 1 with Salubrinal treatment,
upregulating to 1.18x fold-change after 2 hours of treatment, and continues to upregulate further
to its highest expression levels after 5 hours of treatment to 5.17x fold-change. Then, the
expression levels slowly begin to decline till about 36 hours to 1.08x fold-change (Figure 13A).
With Tunicamycin treatment, BiP expression with primer set 1was shown to upregulate at 3
hours of treatment to about 2.46x fold-change (Figure 12B). The expression continued to
upregulate after 5 hours of treatment to 4.90x fold-change. After 5 hours, the expression levels
started to downregulate till 48 hours of treatment to 1.24x fold-change. BiP expression with
primer set 2 has a similar expression pattern, upregulating to 1.17x fold-change after 2 hour of
treatment, and continues to upregulate, peaking at 6 hours of treatment with a 8.46x fold-change
(Figure 13B). Between 6 hours to 48 hours of treatment, the expression of BiP with primer set 2
steadily declined from 8.46x fold-change to 1.11x fold-change. With Thapsigargin treatment,
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BiP expression with primer set 1 was shown to upregulate at 3 hours of treatment to 8.65x foldchange and continues to steadily increase till 8 hours of treatment to 14.78x fold-change (Figure
12C). During chronic-ER stress, from 10 hours to 48 hours, the expression of BiP with primer
set 1 steadily declines back to baseline to 1.94x fold-change. Similar to BiP expression with
primer set 1, BiP expression with primer set 2 upregulates to 5.02x fold-change with
Thapsigargin treatment and continues to upregulate readily till 5 hours of treatment to 16.37x
fold-change (Figure 13C). The expression of BiP gene with primer set 2 downregulates steadily
about 8 hours to 36 hours of treatment from 14.15x fold-change to -0.89x fold-change, below
baseline.
Together, this data suggests that with ER stress induction, BiP expression upregulates
slightly with Salubrinal treatment but increases readily during early-phase of ER stress with
Tunicamycin and Thapsigargin treatment (Figure 12D and Figure 13D). This data fits the model
seen previously for the human UPR profiling: BiP expression increases with the induction of ER
stress since it is the first protein that acts with the presence of ER stress. Furthermore, with ER
stress, all three UPR pathways are activated, and the major downstream target of all three
pathways is the upregulation of chaperone proteins (illustrated in Figure 1).
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Figure 12. Changes in BiP Expression with Primer Set 1 with ER Stress Induction. Zebrafish
was treated with Salubrinal, Tunicamycin, and Thapsigargin (controls were treated with DMSO
in E3 embryos media) for 1, 2, 3, 4, 5, 6, 8, 10, 12, 20, 24, 36, and 48 hours, starting at 24 hpf.
RNA was isolated and purified, and RT-qPCR was performed. dCt values were calculated by
normalization to eF1α, and ddCt values were calculated by normalization to DMSO. Fold
changes (2-ddCt) were calculated based on mean ddCt values. Error bars represent the standard
error of the ddCt mean. Statistical significance was determined using a one-sample t-test, with
significant differences indicated (*) when p<0.05. A. BiP expression with primer set 1 treated
with Salubrinal [50μM]. B. BiP expression with primer set 1 treated with Tunicamycin
[2.5µg/mL]. C. BiP expression with primer set 1 treated with Thapsigargin [1µM]. D.
Combination of BiP expression with primer set 1 with all three drug treatments.
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Figure 13. Changes in BiP Expression with Primer Set 2 with ER Stress Induction. Zebrafish
was treated with Salubrinal, Tunicamycin, and Thapsigargin (controls were treated with DMSO
in E3 embryos media) for 1, 2, 3, 4, 5, 6, 8, 10, 12, 20, 24, 36, and 48 hours, starting at 24 hpf.
RNA was isolated and purified, and RT-qPCR was performed. dCt values were calculated by
normalization to eF1α, and ddCt values were calculated by normalization to DMSO. Fold
changes (2-ddCt) were calculated based on mean ddCt values. Error bars represent the standard
error of the ddCt mean. Statistical significance was determined using a one-sample t-test, with
significant differences indicated (*) when p<0.05. A. BiP expression with primer set 2 treated
with Salubrinal [50μM]. B. BiP expression with primer set 2 treated with Tunicamycin
[2.5µg/mL]. C. BiP expression with primer set 2 treated with Thapsigargin [1µM]. D.
Combination of BiP expression with primer set 2 with all three drug treatments.

Effects of Salubrinal, Tunicamycin, and Thapsigargin Treatment on UPR Specific Genes
After comparing the effects of each treatment (Salubrinal, Tunicamycin, and
Thapsigargin) on gene expression changes for each UPR-specific gene, we combined data from
the different trials. Since the goal of this experiment is to understand the effects of drugs on
UPR genes, displaying the data two different ways allows us to compare the variables
differently: 1) observing the effects of the three treatments on a specific gene and 2) observing
the changes in expression of the five genes within each treatment.
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With Salubrinal treatment, GADD34 and CReP generally remain at baseline, without
much change in expression. This data suggests that Salubrinal has an inhibitory effect on
GADD34 and CReP expression, which can therefore result in the decrease of eIF2α complex
formation, thereby decreasing the functional effects of PP1 to dephosphorylate eIF2α. CHOP
expression is detected below baseline expression with Salubrinal treatment, hence implying that
late-phase UPR is not activated with this pharmacological treatment. In the working model of
the UPR signaling pathway, it is seen that CHOP is activated with prolonged ER stress, and with
GADD34 and CReP inhibited, the UPR does not progress, hence not having a significant effect
on the expression of CHOP. Finally, BiP levels (with both BiP-1 and BiP-2) seem to increase
slightly around 6 hours of Salubrinal treatment, which could be a result of increased chaperone
proteins from the activation of an alternative pathway (Figure 14A). All the data on the effects
of Salubrinal on gene expression does not lead to clear conclusions due to the absence of ER
stress, which is necessary for Salubrinal to have an effect due to the activation of the UPR
pathway. Further experiments must be conducted with co-treatments with Salubrinal and an ER
stress inducers to better understand the effects of Salubrinal on the expression of UPR-specific
genes.
With Tunicamycin treatment, it can be observed that there are changes in all the genes
expression with the induction of ER stress. GADD34 expression upregulates at about 4 hours of
treatment and progresses with just a slight downregulation from 6 hours to 48 hours, back to
baseline activity. CReP, on the other hand, upregulates at about 8 hours of treatment (later than
GADD34), and declines rapidly from 10 hours to 48 hours, back to below baseline. This data
suggests that Tunicamycin induces ER stress, hence activating the UPR pathway. With earlyphase UPR (0 hours to 4 hours of treatment), GADD34 expression is upregulated with the
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activation of ATF4 (illustrated in figure 3), which is suggested to be the transcriptional activator
of GADD34. CReP is thought to be constitutively active, but the data suggests that CReP
expression is dynamically induced with ER stress induction, allowing for its expression to
increase shortly after the early phase-UPR, and decline during chronic phase-UPR. CHOP
expression with Tunicamycin treatment is observed to upregulate at about 5 hours of treatment
and remains upregulated throughout the duration of ER stress induction. This data suggests that
Tunicamycin allows for the upregulation of CHOP and maintains its high gene expression during
late-phase UPR with chronic ER stress, which fits the model of CHOP being a late-phase UPR
protein. Finally, BiP (both BiP-1 and BiP-2) expression increases rapidly with Tunicamycin
stress and increases more than the other genes being studied. This fits the model because BiP
protein is the first protein that is activated with ER stress induction, from unbinding from the
three transmembrane UPR proteins and being the main downstream target for all three pathways
when activated (Figure 14B).
With Thapsigargin treatment, it can be observed that there is a similar pattern of
expression as Tunicamycin treatment, with GADD34 expression upregulating at about 4 hours of
treatment and progressing with just a slight downregulation from 6 hours to 48 hours. CReP
upregulates to its highest expression at about 8 hours of treatment (later than GADD34), and
declines rapidly from 10 hours to 48 hours, back to below baseline. This data shows that
Tunicamycin and Thapsigargin have similar effects on GADD34 and CReP expression, with the
induction of ER stress. CHOP expression with Thapsigargin is also similar to Tunicamycin,
upregulating at about 4 hours of treatment, and remains elevated through the entire duration of
ER stress induction with Thapsigargin. This data suggests that Thapsigargin allows for the
upregulation of CHOP and maintains its high gene expression during late-phase UPR with
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chronic ER stress, similar to Tunicamycin. Finally, with Thapsigargin treatment, BiP expression
increases rapidly with the induction of stress and declines rapidly during chronic ER stress. This
fits the UPR model that BiP upregulates with ER stress induction, and when the late-phase UPR
is activated, the expression of BiP declines with other proteins being activated to change the fate
of the cell from survival to apoptotic (Figure 14C). Schematics of this data is illustrated in
Figure 14. The figures display a general trend in the changes in the gene expression of the UPRspecific genes with Salubrinal (Figure 15A), Tunicamycin (Figure 15B), and Thapsigargin
(Figure 15C) treatment.
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Figure 14. Effects of Pharmacological Treatment on Gene Expression of UPR-Specific Genes.
Zebrafish was treated with Salubrinal, Tunicamycin, and Thapsigargin (controls were treated
with DMSO in E3 embryos media) for 1, 2, 3, 4, 5, 6, 8, 10, 12, 20, 24, 36, and 48 hours, starting
at 24 hpf. RNA was isolated and purified, and RT-qPCR was performed. dCt values were
calculated by normalization to eF1α, and ddCt values were calculated by normalization to
DMSO. Fold changes (2-ddCt) were calculated based on mean ddCt values. Error bars represent
the standard error of the ddCt mean. A. Salubrinal [50μM] treatment on gene changes of
GADD34 (blue), CReP (yellow), CHOP (green), BiP-1 (magenta), and BiP-2 (brown). B.
Tunicamycin [2.5µg/mL] treatment on gene changes of GADD34 (blue), CReP (yellow), CHOP
(green), BiP-1 (magenta), and BiP-2 (brown). C. Thapsigargin [1µM] treatment on gene changes
of GADD34 (blue), CReP (yellow), CHOP (green), BiP-1 (magenta), and BiP-2 (brown).
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Figure 15. Schematics of Pharmacological Treatment on Gene Expression of UPR-Specific
Genes. A. Schematic of Salubrinal [50μM] treatment on gene changes of GADD34 (blue), CReP
(yellow), CHOP (green), and BiP (magenta). B. Schematic of Tunicamycin [2.5µg/mL]
treatment on gene changes of GADD34 (blue), CReP (yellow), CHOP (green), and BiP
(magenta). C. Schematic of Thapsigargin [1µM] treatment on gene changes of GADD34 (blue),
CReP (yellow), CHOP (green), and BiP (magenta).
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Effects of ER Stress Inducers and Salubrinal on GADD34 mRNA Localization in Zebrafish
Embryos at 4 hours and 24 hours
After studying the changes in gene expression of eIF2α phosphatases when Zebrafish
embryos were treated with ER stress inducers and Salubrinal, we wanted to understand the
mRNA localization patterns of the GADD34 and CReP genes within zebrafish embryos. Since
all the gene expression studies thus far were conducted on the whole embryo, it is vital to
observe the mRNA localization patterns in vivo to determine if there is tissue-specific expression
of these genes. In Pyati et al (2011), it was determined that when whole zebrafish embryos were
treated with Thapsigargin, increased apoptosis was observed in the eye and caudal fin epidermis.
It was also determined that the gene localization patterns of p63-puma and CHOP, two proapoptotic proteins, were present at the head and caudal fin epidermis, at the same place that
apoptosis was occurring with ER stress induction. Additionally, it was found that p63-puma is an
acute-phase ER stress pro-apoptotic protein allowing for apoptosis at 4 hours post-stress while
CHOP is a late-phase ER stress pro-apoptotic protein allowing for apoptosis at 24 hours poststress. Understanding the expression patterns of these pro-apoptotic genes, we wanted to
understand the localization and expression patterns of the two eIF2α phosphate genes to
determine if these genes are expressed in the head and caudal fin epidermis, to gain a deeper
understanding of UPR signaling.
For these experiments, a previously cloned vector of GADD34 mRNA in the pCS2+ MT
vector (Figure 7) was used to generate sense and antisense RNA probes (negative and
experimental controls, respectively) against GADD34. These probes’ generation was checked
by running a 2% RNA agarose gel (figure not provided). After successfully generating the sense
and antisense probes, they were used to examine expression in zebrafish treated with ER stress
inducers (tunicamycin and thapsigargin) for 4 hours to establish proper positive and negative
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control expression (Figure 16). The antisense probe bound to the GADD34 mRNA of interest,
which is shown by the presence of an indigo color in the embryos’ eye and caudal fin epidermis
(Figure 16B, D), and the sense probe did not bind to any gene, which is indicated by the abscess
of an indigo color in the embryos’ eye and caudal fin epidermis (Figure 16A, C). Once the
probes were correctly designed and their specificity was confirmed, whole mount in-situ
hybridization assay on ER stress induced and Salubrinal treated zebrafish was performed.
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Figure 16. Whole Mount In-Situ Hybridization Displaying GADD34 mRNA Localization at 4
Hours Using Sense and Antisense Probes. Embryos were treated with ER stress inducers for 4
hours starting at 24 hpf. mRNA Localization patterns were assayed via whole mount in-situ
hybridization using sense and antisense probes tagged with digoxigenin, and antibodies tagged
with alkaline phosphatase. Embryos were imaged using the Leica microscope and LASX
imaging software. A. GADD34 mRNA localization with Thapsigargin treatment for 4 hours
using GADD34 sense probe (negative control). B. GADD34 mRNA localization with
Thapsigargin treatment for 4 hours using GADD34 antisense probe (positive control). C.
GADD34 mRNA localization with Tunicamycin treatment for 4 hours using GADD34 sense
probe (negative control). D.GADD34 mRNA localization with Tunicamycin treatment for 4
hours using GADD34 antisense probe (positive control).
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Zebrafish embryos were then raised to 24 hpf and treated with Salubrinal [50µM],
Tunicamycin [2.5µg/mL], and Thapsigargin [1µM] (controls were treated with DMSO in E3
embryos media) for 4 hours and 24 hours. The embryos were fixed with paraformaldehyde
before conducting the whole mount in-situ hybridization protocol. The embryos were imaged
using the LEICA microscope with the LASX imaging software.
In the 24 hpf embryos treated with Salubrinal for 4 hours, we observed there was little to
no expression of the gene when compared to the control DMSO-treated embryos, in the fin
epidermis of the zebrafish at the end of treatment (Figure 17A-B). When treated with
Tunicamycin for 4 hours, we observed that GADD34 expression was more tissue-specific, with
increased induction of expression in the eye and fin epidermis when compared to DMSO
controls indicated by the black arrows at the fin (Figure 17C). Finally, with 4 hours of
Thapsigargin treatment for 4 hours, we observed a similar expression pattern of GADD34
mRNA as seen in the Tunicamycin treatment, with increased induction of expression in the eye
and fin epidermis when compared to DMSO control (Figure 17D); indicated by the black arrows
at the fin. When the results from the localization of expression experiments were compared to
the qPCR expression studies, it can be concluded that GADD34 expression increases with 4
hours of ER stress induction with Tunicamycin and Thapsigargin, resulting in increased
GADD34 expression in the zebrafish eye and fin epidermis, whereas there are no significant
gene expression changes of GADD34 with Salubrinal treatment, presumably because it is a
GADD34 feedback inhibitor, and an inhibitor could increase transcription while blocking the
gene post-translationally.
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Figure 17. Whole Mount In-Situ Hybridization Displaying GADD34 mRNA Localization at 4
Hours. Embryos were treated with the three drugs for 4 hours starting at 24 hpf. mRNA
localization patterns were assayed via whole mount in-situ hybridization using probes tagged
with digoxigenin, and antibodies tagged with alkaline phosphatase. Embryos were imaged using
the Leica microscope and LASX imaging software. Arrows illustrating changes in localization
in the tail of drug treated embryos. A. DMSO treatment used as a control. B. mRNA GADD34
localization imaged with Salubrinal [50μM] treatment. C. mRNA GADD34 localization imaged
with Tunicamycin [2.5µg/mL] treatment. D. mRNA GADD34 localization imaged with
Thapsigargin [1µM] treatment.

Next, in 24 hpf embryos treated with Salubrinal for 24 hours, we observed there was no
additional GADD34 staining when compared to the control DMSO (Figure 18A-B).
Additionally, when zebrafish embryos were treated with Tunicamycin for 24 hours, GADD34
expression was observed to be more tissue-specific, with slightly increased induction of
expression in the eye and fin epidermis when compared to DMSO control (Figure 18C) indicated
by the black arrows at the caudal fin and eye. Finally, with Thapsigargin treatment for 24 hours,
GADD34 displayed minimal or no expression in either the fin epidermis and the eye, similarly to
DMSO, which indicates that Thapsigargin treatment did not influence the localization of
GADD34 (Figure 18D). When the results from the localization of expression experiments were
compared to the qPCR expression studies, similar conclusions can be drawn. With Salubrinal
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treatment, GADD34 expression did not change much as the DMSO control in the qPCR data,
and similarly, in the in-situ mRNA localization studies, GADD34 mRNA localization cannot be
visualized in Salubrinal treated embryos. For Tunicamycin, the qPCR expression studies show
that GADD34 expression plateaus out after increasing from baseline treatment, and similarly,
there is GADD34 mRNA localization observed in the zebrafish embryos at 24 hours. Finally,
with Thapsigargin treatment, GADD34 expression levels retreat to baseline with chronic
exposure to ER stress, which can also be observed in the localization of mRNA assay, with little
to no GADD34 present when compared to the DMSO control.
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Figure 18. Whole Mount In-Situ Hybridization Displaying GADD34 mRNA Localization at 24
Hours. Embryos were treated with the three drugs for 24 hours starting at 24 hpf. mRNA
localization patterns were assayed via whole mount in-situ hybridization using probes tagged
with digoxigenin, and antibodies tagged with alkaline phosphatase. Embryos were imaged using
the Leica microscope and LASX imaging software. Arrows illustrating changes in localization
in the tail of drug treated embryos. A. DMSO treatment used as a control. B. mRNA GADD34
localization imaged with Salubrinal [50μM] treatment. C. mRNA GADD34 localization imaged
with Tunicamycin [2.5µg/mL] treatment. D. mRNA GADD34 localization imaged with
Thapsigargin [1µM] treatment.
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Effects of ER Stress Inducers and Salubrinal on CReP mRNA Localization in Zebrafish
Embryos at 4 hours and 24 hours
In addition to studying the mRNA localization of GADD34 to better understand the
localization of the eIF2α phosphatases, we sought to examine and observe the mRNA
localization of CReP. For these experiments, a previously cloned vector of CReP mRNA in the
pCS2+ MT vector (Figure 7) was used to generate sense and antisense RNA probes (negative
and experimental controls, respectively) against CReP, similar to GADD34. The establishment
of CReP sense and antisense probes is displayed in Figure 19 A-D. The CReP mRNA
localization experiments within the zebrafish embryos were conducted in the same manner as
those of the mRNA localization experiments of GADD34.
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Figure 19. Whole Mount In-Situ Hybridization Displaying CReP mRNA Localization Using
Sense and Antisense Probes. Embryos were treated with ER stress inducers for 4 or 24 hours
starting at 24 hpf. mRNA localization patterns were assayed via whole mount in-situ
hybridization using sense and antisense probes tagged with digoxigenin, and antibodies tagged
with alkaline phosphatase. Embryos were imaged using the Leica microscope and LASX
imaging software. A. CReP mRNA localization with Thapsigargin treatment using CReP sense
probe (negative control). B. CReP mRNA localization with Thapsigargin treatment using CReP
antisense probe (positive control). C. CReP mRNA localization with Tunicamycin treatment
using CReP sense probe (negative control). D. CReP mRNA localization with Tunicamycin
treatment using CReP antisense probe (positive control).

In the 24 hpf embryos treated with Salubrinal for 4 hours, we observed there was a little
CReP staining in the caudal fin epidermis when compared to the DMSO controls (Figure 20AB). Since Salubrinal is known to inhibit the complex formation of GADD34 and CReP with
PP1, it appears that Salubrinal may have a stronger effect on inhibiting GADD34 than CReP as
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seen when comparing the mRNA localization data from the two genes at 4 hours. When the
zebrafish embryos were treated with Tunicamycin for 4 hours, we observed that CReP
expression was similar to GADD34 expression in that it is more tissue-specific, with increased
induction of expression in the eye and fin epidermis when compared to DMSO control (Figure
20C) indicated by the black arrows (at the fin). Finally, with Thapsigargin treatment for 4 hours,
we observed that CReP expression once again had a similar expression pattern as GADD34 with
Thapsigargin treatment, with increased induction of expression in the eye and fin epidermis
when compared to DMSO control (Figure 20D) indicated by the black arrows (at the fin). When
the results from the mRNA localization experiments were compared to the gene expression
studies, it can be concluded that CReP expression increases with 4 hours of ER stress induction
with Tunicamycin and Thapsigargin, resulting in increased CReP expression in the zebrafish eye
and fin epidermis, whereas there is a slight increase in the gene expression changes of CReP
shown in both the qPCR and mRNA localization experiments.
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Figure 20. Whole Mount In-Situ Hybridization Displaying CReP mRNA Localization at 4
Hours. Embryos were treated with the three drugs for 4 hours starting at 24 hpf. mRNA
localization patterns were assayed via whole mount in-situ hybridization using probes tagged
with digoxigenin, and antibodies tagged with alkaline phosphatase. Embryos were imaged using
the Leica microscope and LASX imaging software. Arrows illustrating changes in mRNA
localization in the tail of drug treated embryos. A. DMSO treatment used as a control. B. CReP
mRNA localization imaged with Salubrinal [50μM] treatment. C. CReP mRNA localization
imaged with Tunicamycin [2.5µg/mL] treatment. D. CReP mRNA localization imaged with
Thapsigargin [1µM] treatment.

Moreover, in 24 hpf embryos treated with Salubrinal for 24 hours, we observed there was
no presence, when compared to the control DMSO, of CReP expression in the fin epidermis or
eye of the zebrafish at the end of treatment (Figure 18A-B). Additionally, when zebrafish
embryos were treated with Tunicamycin and Thapsigargin for 24 hours, CReP expression was
minimal or no expression at both the fin epidermis and the eye, similarly to DMSO, which
indicates that Tunicamycin and Thapsigargin treatment did not influence the expression of
CReP, hence the localization of CReP mRNA was not-present (Figure 18D). When the results
from the localization of expression experiments were compared to the gene expression studies,
similar conclusions can be drawn. With Salubrinal, Tunicamycin and Thapsigargin treatment,
CReP qPCR expression did not change much when compared to the DMSO control treatment in
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the qPCR data or retreated to baseline, and similarly, in the in-situ mRNA localization studies,
CReP mRNA localization cannot be visualized in all three drug-treated embryos. This suggests
that the localization of expression experiments and qPCR expression experiments supported the
same conclusion: that with acute ER stress, there is an increase in the expression and mRNA
localization of CReP but with chronic ER stress, there is a decrease/downregulation in the
expression and localization of the CReP gene.
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Figure 21. Whole Mount In-Situ Hybridization Displaying CReP mRNA Localization at 24
Hours. Embryos were treated with the three drugs for 24 hours starting at 24 hpf. mRNA
localization patterns were assayed via whole mount in-situ hybridization using probes tagged
with digoxigenin, and antibodies tagged with alkaline phosphatase. Embryos were imaged using
the Leica microscope and LASX imaging software. Arrows illustrating changes in localization
in the tail of drug treated embryos. A. DMSO treatment used as a control. B. CReP mRNA
localization imaged with Salubrinal [50μM] treatment. C. CReP mRNA localization imaged with
Tunicamycin [2.5µg/mL] treatment. D. CReP mRNA localization imaged with Thapsigargin
[1µM] treatment.
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CHAPTER 4: DISCUSSION

Two distinct genetic programs for cell death have been found to occur in response to ER
stress induction in zebrafish caudal fin epidermal cells (Pyati et al., 2011). Apoptosis occurring
at 4 hours post-stress induction was attributed to a p63-puma apoptotic pathway, while apoptosis
seen at 24 hours was CHOP-dependent. A previous graduate student in the Weiser lab
conducted studies with GADD34 and CReP overexpression and knockdown in order to
determine their roles within the caudal fin apoptotic pathway. It was found that overexpression
of GADD34 with acute ER stress (4 hours of ER stress induction) appeared to have a protective
effect on apoptosis, leading to decreased apoptotic cells within the caudal fin of the zebrafish
embryos, but there was no effect on chronic stress. On the other hand, the knockdown of
GADD34 with chronic ER stress (24 hours of ER stress induction) GADD34 was found to have
a protective effect on apoptosis within the caudal fin of the zebrafish embryos. Finally, findings
showed that knockdown of both GADD34 and CReP appeared to have a protective effect at both
acute and chronic stages of ER stress. From these results, we wanted to better understand the
expression patterns of GADD34 and CReP, as well as other UPR specific genes, such as BiP and
CHOP, to develop a detailed profile of the UPR in zebrafish. The results of our studies show
that the dynamic expression of GADD34 and CReP in zebrafish differs from that of mammalian
cells, as well as differences in the expression patterns of downstream genes of the UPR.
Dynamic Expression of UPR-Specific Genes in Mammals
The dynamic expression of UPR-specific genes has been studied in mammals using
mouse embryonic fibroblast (MEFs) cells. mRNA gene expression changes were observed for
CHOP, ATF4, and CReP in WT MEF’s and GADD34 -/- MEF’s (Reid et al., 2016). The
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dynamics of UPR progression from the early to late stage provide the foundational framework
for interpreting the results of dynamic expression of UPR-specific genes in mammals.
The study conducted by Reid et al. (2016) suggested that the early-phase UPR is focused
on translational suppression and degradation of misfolded proteins, while the late-phase UPR
enhances ER protein folding capacity through increased synthesis of ER chaperone proteins. A
normal response to ER stress in WT MEF’s illustrates elevated levels of eIF2α phosphorylation
between 30 minutes and 1 hour of ER stress induction via Thapsigargin treatment. GADD34
protein is induced to significant levels by 2 hours of ER stress induction and acts to progress the
UPR in two main ways: 1) by resuming protein translation by reducing levels of phosphorylated
eIF2α to near-baseline levels by 4 hours, and 2) by returning previously released mRNAs of ERtargeted proteins back to the ER. After 2 hours of Thapsigargin treatment, it was seen that
GADD34 levels rose steadily, which was consistent with the ER stress-enhanced transcription of
GADD34 gene, which suggests that ER stress promotes the transcription of the GADD34
mRNA, which in turn makes a significant contribution of the cellular levels of the GADD34
protein (Lee et al., 2009; Reid et al., 2016).
In WT MEFs, the translational activation of ATF4 and CHOP began at 30 minutes of ER
stress and protein expression increased in a time-dependent manner to significantly higher levels
by 4 hours. The authors further continued their research by investigating the long-term effects of
ER stress induction on MEFs. They found that in WT MEFs, eIF2α phosphorylation was
reversed by 8 hours of ER stress induction via Thapsigargin exposure. It was also found that
between 18 hours and 24 hours of ER stress induction, the ATF4 and CHOP genes have
significantly retreated to baseline levels.
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They further focused on the expression patterns of CReP within WT MEFs. Earlier
research studies showed that CReP protein levels did not change in response to cell stress (Jousse
et al., 2003), but further work has suggested that the activation of the IRE1α pathway in response
to ER stress leads to the degradation of the CReP mRNA (So et al., 2015), which leads to the
reduction of the CReP protein, in turn increasing eIF2α phosphorylation and attenuation of
protein synthesis. Reid et al., analyzed CReP mRNA in MEFs exposed to Thapsigargin
treatment and found that CReP mRNA levels were constant in Thapsigargin treated WT MEFs
over 16 hours, which is consistent with previous studies that there is no change in CReP mRNA
levels over 24 hours of Thapsigargin exposure in the WT MEFs (Reid et al., 2016).
Effects of Tunicamycin and Thapsigargin on the Dynamic Expression of UPR-Specific
Genes in Zebrafish
As mentioned previously, Thapsigargin is a potent and highly specific ER stress inducing
drug in mammalian cells that works by disrupting calcium homeostasis by acting as a calcium
pump inhibitor (Thastrup et al., 1990). Tunicamycin, on the other hand, induces ER stress in
cells by inhibiting N-glycosylation of proteins, resulting in misfolded proteins, therefore
blocking the proteins entry through the secretory pathway, and resulting in their accumulation in
the ER (Wu et al., 2018 and Guha et al., 2017). Both drugs have been shown and proven to
induce ER stress, allowing us to study the effects of ER stress on different pathways within the
zebrafish embryos. Previous research studies have observed the effects of different types of ER
stress and their effects on gene expression levels. Dendritic cells (DC’s) are regulators of the
immune response, and they have the capability to induce differentiation of naive T cells through
cytokine production and optimize their antigen presentation capacity (Clavarino et al., 2012).
These cells have an excellent pattern of differentiation that drives different mechanisms to
control the immune system. One such mechanism being that in response to polyriboinosinic:
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polyribocytidylic acid (pI:C), these cells drive the expression of the integrated stress response
(ISR). The study shows that DC stimulation by pI:C induces the expression of GADD34 and
CReP; the mRNA transcription of GADD34 was enhanced at least 14-fold and mRNA
transcription of CReP was enhanced about 2-fold, which differs slightly from the expression of
UPR genes seen within the WT MEFs treated with Thapsigargin exposure.
For our experiments, we wanted to focus on how these genes change in expression within
zebrafish to determine the effectiveness of this organism to act as a model organism. Our results
show that GADD34 and CReP expression both significantly increased at about 4 hours with both
Tunicamycin and Thapsigargin treatment and continued to upregulate throughout the acute ER
stress time-period, till about 8 hours. Following the 8-hour time-point, GADD34 expression
with Tunicamycin treatment remained elevated but plateaued at about 1.5-fold. With
Thapsigargin treatment, GADD34 expression receded during chronic ER stress. This differs
from the mammalian gene expression pattern of GADD34. In Reid et al. it was seen that with
Thapsigargin treatment, GADD34 levels rose steadily after 2 hours of Thapsigargin exposure
and remained elevated with chronic ER stress. The results obtained for GADD34 expression
with Tunicamycin treatment are more in line with what was seen with the dynamic expression of
GADD34 in mammalian cells. CReP expression levels, on the other hand, receded back to
baseline with both Tunicamycin and Thapsigargin treatment during chronic ER stress between
10 hours and 48 hours. Reid et al. (2016), CReP’s expression differs from the mammalian
expression, in that CReP expression levels change in response to ER stress inducers which was
not seen in the WT MEFs treated with Thapsigargin treatment. The results from our studies
show that there is dynamic expression of both GADD34 and CReP mRNA levels with ER stress
inducers in zebrafish, and this expression pattern differs from that seen in mammalian cells.
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The quantitative PCR findings on the changes in mRNA levels of gene expression of
GADD34 and CReP with ER stress induction can be supported by whole mount in-situ
hybridization of GADD34 and CReP mRNA localization. In Pyati et al. (2011), it was found
that p63 and CHOP localized differently and at different times of exposure with ER stress.
Apoptosis can be initiated through two distinct genetic programs in response to ER stress,
depending on the length of stress exposure. Research by Pyati et al. found an acute cell death
response after 4 hours of ER stress mediated by p63 and puma and found a chronic cell death
response after 24 hours of ER stress dependent on CHOP. The upstream signals involved in
activating each of these apoptotic responses have not been clearly identified, and more
specifically, the role of eIF2α phosphatases in this process was unknown. We wanted to
understand whether the patterns of localization of expression of the GADD34 and CReP genes
can correspond to activate these apoptotic responses.
We found that with 4 hours of ER stress induction via Tunicamycin and Thapsigargin
exposure, GADD34 and CReP localize to the caudal fin epidermis and the eye of the zebrafish.
This was supported by the qPCR data for 4 hours as it was seen that GADD34 expression was
high at about 2.5-fold with Tunicamycin treatment and 5.5-fold with Thapsigargin at 4 hours and
CReP expression was high at about 2.5-fold with Tunicamycin treatment and 7-fold with
Thapsigargin treatment. In the localization assays, both GADD34 and CReP localized to the fin
epidermis and eye, with increased staining indicating a high gene expression during the 4-hour
treatment with the two ER stress inducers. Additionally, with 24 hours of ER stress induction
via Tunicamycin and Thapsigargin exposure, we found that there was little to no GADD34 and
CReP mRNA localization at the fin epidermis and eye with Thapsigargin treatment. When
compared with the qPCR results at the 24-hour time point, it was seen that GADD34 and CReP
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expression was downregulated by about 0.5-fold. However, minimal mRNA localization was
seen of GADD34 gene with Tunicamycin treatment at the 24-hour time point, which is also
supported by the qPCR data indicating that GADD34 expression was increased to about 1.5fold.
Although both the gene expression data have similar concluding results, further work
testing overexpression and knockdown of these genes must be performed to better understand
their role in caudal fin apoptosis and their effects on UPR signaling. Reid et al. (2016) showed
that MEF cells lacking GADD34 exhibited elevated eIF2α phosphorylation till about 8 hours
after ER stress induction with decline in phosphorylation not occurring until 18-24 hours poststress induction. Without GADD34, prolonged elevation of phosphorylated eIF2α is active for
14-20 additional hours compared to WT MEF cells. Further experiments with zebrafish with
GADD34 and CReP knockouts via morpholino injections should be done to establish the
dynamic gene expression pattern of these genes within zebrafish and get a better understanding
of the relationship between mammalian cells.
In addition to GADD34 and CReP, the dynamic expression of the CHOP and BiP
mRNAs were also observed with ER stress induction. As previously mentioned, in Reid et al.
(2016), it was found that CHOP expression began at 30 minutes of ER stress, and the expression
continued to increase in a time-dependent manner to peak levels by 4 hours in WT MEFs.
Between 18 hours to 24 hours, CHOP levels retreated to baseline levels. Our results suggested
that CHOP expression began at about 4 hours and continued to increase in a time-dependent
manner through 48 hours with chronic ER stress, with both Tunicamycin and Thapsigargin
treatment. CHOP is a mediator of the later-phase apoptotic pathway (Pyati et al., 2011) and is
found to have short mRNA and protein half-lives, needing chronic PERK activation to promote
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high levels of CHOP (Wang and Kaufman., 2014). Our data is consistent with the understanding
that constant ER stress, which activates the PERK pathway constantly, is necessary for high
levels of CHOP levels. In Pyati et al. CHOP levels were seen to be elevated with 24 hours of
Thapsigargin treatment seen by whole mount in-situ hybridization results.
Finally, we focused on observing the dynamic expression of the BiP gene during ER
stress induction with both acute and chronic ER stress. BiP, a 78-kDa glucose-regulated protein
and ER molecular chaperone, is a major UPR-regulated target protein. BiP is involved in many
cellular processes, including but not limited to: translocating newly synthesized polypeptides
across the ER membrane, facilitating in the folding and assembly of newly synthesized proteins,
and regulating Ca2+ homeostasis (Lee, 2001; Hendershot, 2004). BiP is also a key regulator of
ER stress transducers; it binds and inhibits PERK, IRE1α, and ATF6 activation in unstressed
cells (Bertolotti et al., 2000). With the presence of ER stress, which leads to the accumulation of
misfolded proteins, BiP unbinds from the ER stress transducers and the pathways get activated
(Li et al., 2008). Not much is known about the dynamic expression of BiP in mammalian cells,
but it is hypothesized that with chronic exposure to stress, there is an upregulation of the BiP
gene in a time-dependent manner before plateauing. This is believed to be the case because BiP
is the primary target protein of the UPR signaling pathways. The downstream effect of all three
of the UPR pathways is the upregulation of ER chaperone proteins, primarily BiP, to help
alleviate the stress caused by misfolded and unfolded proteins in the endoplasmic reticulum.
For our experiments, we designed two primers that target the BiP gene to observe its
changes in expression with the induction of ER stress. We observed that BiP expression levels
begin to increase at about 2 hours and steadily increase till about 10 hours, after which they
retreat to baseline levels for both Tunicamycin and Thapsigargin treatment. We hypothesize that
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this may be the case because with chronic ER stress, cells have been shown to progress through
apoptotic pathways since the ER stress is well over the capacity for the restoration of
homeostasis. Compared to the other four genes that we observed, BiP expression was the fastest
gene to upregulate its expression, which is potentially because it is the main downstream target
for all three pathways of the UPR.
Our results, although different from what was seen in the WT MEFs dynamic expression
of UPR-Specific genes, still provides insight on the signaling patterns of these genes within
zebrafish embryos. Further experiments of knockdowns, via morpholinos, and overexpression
studies must be performed to understand how these genes truly interact with each other and how
their expression patterns are similar or different from WT MEF mammalian cells.
Effects of Salubrinal on the Dynamic Expression of UPR-Specific Genes in Zebrafish
Multiple small molecule drugs have been found to inhibit the function of eIF2ɑ
phosphatases, such as GADD34 and CReP, in vivo. As mentioned previously, Salubrinal is a
drug that specifically blocks serine/threonine phosphatase-dependent dephosphorylation of eIF2α
by inhibiting the PP1 complexes that form with both GADD34 and CReP (Boyce et al., 2005).
Although it acts as an eIF2α phosphatase inhibitor that blocks both GADD34 and CReP function,
its mechanism of action is not currently known. It was found that mice models of ALS and
Parkinson’s Disease show a protective effect from inhibiting eIF2α phosphatases by Salubrinal
treatment (Saxena et al., 2009; Colla et al., 2012). This is attributed to the stalling of UPR
progression, allowing clearance of accumulated misfolded ER proteins and potential removal of
damaged ER via autophagy. Furthermore, several research studies have shown the various prosurvival benefits of Salubrinal treatment and how it may protect cells against ER stress-induced
apoptosis. Salubrinal has the ability to protect PC12 cells from ER stress-induced apoptosis by
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Tunicamycin and allows for the enhancement of eIF2α phosphorylation (Boyce et al., 2015). It
is able to do this by reducing several markers of apoptosis, such as caspase-7 processing, the
activity of caspase-3 and caspase-7 type enzymes, and DNA fragmentation in PC12 cells treated
with Tunicamycin (Boyce et al., 2015). Decreased apoptosis was also seen with Salubrinal
treatment in ER stress induced murine leukemia cells (Kessel, 2006). Salubrinal prevented the
inactivation of an anti-apoptotic protein Bcl-2 to protect these cells from photodamage. Various
studies reveal that Salubrinal may interact directly with apoptotic pathways to protect cells from
ER stress-induced apoptosis.
In the previous apoptotic experiments performed by a former graduate student, it was
shown that Salubrinal had protective effects on apoptosis during both acute and chronic ER
stress by blocking the activity of GADD34 and CReP. We wanted to better understand
Salubrinal’s effect on gene expression levels of UPR specific genes to 1) answer questions about
GADD34 and CReP expression patterns and 2) to better understand the mechanism and effects
of Salubrinal.
Our results show that GADD34 expression and CReP expression were both significantly
low, staying right around baseline expression activity with Salubrinal treatment. This indicates
that Salubrinal may have an inhibitory effect on WT GADD34 and CReP expression without ER
stress induction at a transcriptional level, blocking the expression of these genes through both
acute and chronic drug treatment. In addition, Salubrinal showed decreased expression and
localization of GADD34 and CReP genes in whole mount in-situ experiments, further
concluding that it has an inhibitory effect on GADD34 and CReP. Although the data from these
experiments is useful in understanding the mechanism of Salubrinal, it is not sufficient. A major
limitation to this study was that there was no induction of ER stress prior to treatment with
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Salubrinal because we solely wanted to understand the effects of Salubrinal on WT zebrafish
embryos. To further this study and gain a better understanding about Salubrinal, ER stress
should be present to determine if Salubrinal indeed influences GADD34 and CReP expression
and gene localization.
Future Directions
A wide array of future experiments would further the research in this study and contribute
to a deeper understanding of the role of eIF2α phosphatases in ER stress and gain a clear
interpretation of the UPR profiling, as depicted in Figure 22. The first major goal is to further
the UPR profiling studies by conducting more qPCR and whole mount in-situ hybridization
(similar to the experiments conducted in this paper) with varying conditions to get a clear
perception of the expression patterns of UPR-specific genes. To gain these results, qPCR and
whole mount in-situ hybridization must be performed with co-treatments of the pharmacological
agents used, as well as knockdowns of GADD34 and CReP. For the co-treatment experiments,
as well as the GADD34 and CReP knockdown experiments, we want to be able to understand the
compensation and complementation patterns of the two major genes of interest in our lab. With
co-treating Thapsigargin and Tunicamycin with Salubrinal, ER stress will be induced via
Thapsigargin or Tunicamycin while simultaneously blocking the activity of GADD34 and CReP
via Salubrinal. This will help to look at the effects of GADD34 and CReP knockdowns on the
downstream targets of the UPR, allowing to observe gene expression patterns with the induction
of ER stress and the absence of eIF2α phosphatases. This set of experiments will allow us to
understand whether the UPR will be stalled or will continue to progress, which can ultimately
help determine whether therapies that inhibit eIF2α phosphatases may improve disease
phenotypes. GADD34 and CReP morpholino knockdown experiments will help us to better
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understand the compensatory mechanisms (if any) between these two eIF2α phosphatases.
Having GADD34 or CReP morphants, we can perform qPCR and whole mount in-situ
hybridization to look at the changes in the opposing eIF2α phosphatase to determine if knocking
out GADD34 is compensated by CReP or vice-versa. This set of experiments will also help
determine the effects of these eIF2α phosphatases on the downstream signaling of the UPR to
determine whether one phosphatase has a higher impact than the other.

Figure 22. Diagram Outlining Future Research Directions.
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Next, we would like to determine whether GADD34 and CReP contribute to apoptosis in
a CHOP-dependent or p63-dependent manner. This can be accomplished through injecting
morpholinos targeting CHOP and p63 into WT, GADD34 mutant, CReP mutant, and double
mutant embryos (already have established mutant zebrafish cell lines). If GADD34 and CReP
protect cells by regulating CHOP, then we hypothesize that CHOP loss-of-function in the WT
should show no difference in apoptosis relative to the mutants.
Subsequently, we would like to perform further experiments exploring the transcriptional
and translational regulation of GADD34 and CReP in order to understand the regulatory
mechanisms of these two eIF2α phosphatases. Both zebrafish mRNAs for GADD34 and CReP
contain two open reading frames (ORFs) upstream of the primary protein, which is similar to the
mammalian homologs and the fly homolog (Lee et al., 2009). Due to this, we believe that both
the GADD34 and CReP mRNAs must be translationally regulated and would be expected to be
better translated under eIF2α phosphorylation conditions. To obtain these results, we would like
to test cloned reporter constructs that contain the 5’UTR of GADD34 and CReP. The UTR is
fused upstream of a firefly luciferase in the pGL2 vector. This construct will be transfected into
HEK293T cells, will be subjected to ER stress induction, and a Dual Luciferase Reporter Assay
will be performed. This assay will allow us to directly test the relative importance of each uORF
in transcriptional and translational regulation.
Finally, we would like to determine the changes in protein expression levels of GADD34
and CReP via Western Blotting. To complement the qPCR analysis results from the experiments
in this paper, we would like to perform a time course analysis across the different time points and
observe the changes in GADD34, CReP, and eIF2α phosphorylation. We have successfully
cloned multiple fragments of GADD34 and CReP into pQE80 vectors and expressed them into
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BL21 (DE3) RPIL cells and performed nickel affinity chromatography purification in order to
generate antibodies against GADD34 and CReP (which were not commercially available).
These results will help us understand the changes in GADD34 and CReP protein levels and will
allow us to draw conclusions on the signaling profiling of the UPR.
Certainly, there is much left to be understood regarding the roles of GADD34 and CReP
in the UPR and their role in determining the fate of a cell in response to ER stress. Nonetheless,
the results we have thus far obtained in the Weiser lab, spanning the protective effects of
inhibiting eIF2α phosphatases and overexpressing GADD34 to understanding their gene
expression patterns provides insight into treatment options for diseases that can be accomplished
through the manipulation of GADD34 and CReP. Being able to gain a concise discernment of
the UPR profiling can help to open many different avenues to help alleviate disease phenotypes.
In diseases affected by cell death resulting from chronic ER stress and prolonged UPR signaling,
therapies that inhibit eIF2α phosphatases may improve disease phenotypes by stalling
progression of the UPR.
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APPENDIX A: CREP MAMMALIAN PRELIMINARY FINDINGS

A previous graduate student in the Weiser/Wrischnik lab, who was focused on observing
the protein translational effects of GADD34 and CReP in mammalian cells, observed a change in
the molecular weight of CReP in Hep3B cell-line when treated with ER stress inducers, such as
Bleomycin and Rotenone. ER stress is known to be caused by conditions that disturb the
processing and folding of proteins, resulting in the accumulation of unfolded and misfolded
proteins (Wu and Kaufman, 2006), and ER stress was shown to be involved in the regulation of
myofibroblastic differentiation in pulmonary fibrosis (Bael et al., 2012). Bleomycin was
suggested to induce a direct fibrogenic effect on lung fibroblasts by upregulating collagen
expression and cell proliferation through the P13K/AKT pathway (Lu et al., 2010). Rotenone,
on the other hand, is a mitochondrial respiratory chain complex I inhibitor and blocks contact
between complex I and ubiquinone, which is an electron carrier and increases ROS production,
decreases ATP production, and increases the expression levels of ER stress markers (Barrientos
et al., 1999; Aoyama et al., 2021). The changes in the molecular shift were seen with
endogenous CReP when Hep3B cells were treated with 50µM of Rotenone and 20µM of
Bleomycin. The shift appeared to be a molecular shift down, allowing us to believe it might be a
dephosphorylation of CReP with ER stress inducers.
To confirm these results, CReP WT, CReP 11A, and CReP 31A, all tagged with HA,
were cloned into pcDNA3.1(+) vector (Figure 23) and transfected into Human Embryonic
Kidney Cells (HEK293T) and Hep3B cells. The CReP 11A mutant has two consensus sites
mutated, meaning that two phosphorylation sites were removed. The CReP 31A mutant includes
the mutation of all the phosphorylation sites in the CReP structure (Loveless et al., 2015). We
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wanted to determine if the WT CReP signified one of the mutant versions of CReP with two or
all phosphorylation sites deleted. The three CReP clones were transfected into HEK293T cells
and Hep3B cells, and treated with DMSO (as a control), Rotenone (50µM), and Bleomycin
(20µM) for 4 and 24 hours. The cells were lysed, the protein was loaded onto SDS-PAGE gels,
and Western Blot analysis using HA-antibodies was performed.

Figure 1A. Vector Map of pcDNA3.1.
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HEK293T cells treated with ER stress inducers for 4 hours and 24 hours did not show a
significant band size as expected (Figure 24 and Figure 25). Only the 4-hour drug treatment for
Hep3B cells was obtained (Figure 26) because the cells could not tolerate the induction of ER
stress for 24 hours. For all three western blots, a change in the molecular weight of WT CReP
was not observed.

Figure 24. CReP Expression in Mammalian HEK293T Cells Treated for 4 hours with ER Stress
Inducers. HEK293T cells were transfected with 1.5µg of cloned pcDNA3.1 with CReP and
treated for 4 hours with ER stress inducers. Lane 1: 250kDa ladder. Lane 2: WT CReP treated
with DMSO. Lane 3: WT CReP treated with 20µM Bleomycin. Lane 4: WT CReP treated with
50µM Rotenone. Lane 5: 11A CReP treated with DMSO. Lane 6: 11A CReP treated with
20µM Bleomycin. Lane 7: 11A CReP treated with 50µM Rotenone. Lane 8: 31A CReP treated
with DMSO. Lane 9: 31A CReP treated with 20µM Bleomycin. Lane 10: 31A CReP treated
with 50µM Rotenone.
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Figure 25. CReP Expression in Mammalian HEK293T Cells Treated for 24 hours with ER Stress
Inducers. HEK293T cells were transfected with 1.5µg of cloned pcDNA3.1 with CReP and
treated for 4 hours with ER stress inducers. Lane 1: 250kDa ladder. Lane 2: WT CReP treated
with DMSO. Lane 3: WT CReP treated with 20µM Bleomycin. Lane 4: WT CReP treated with
50µM Rotenone. Lane 5: 11A CReP treated with DMSO. Lane 6: 11A CReP treated with
20µM Bleomycin. Lane 7: 11A CReP treated with 50µM Rotenone. Lane 8: 31A CReP treated
with DMSO. Lane 9: 31A CReP treated with 20µM Bleomycin. Lane 10: 31A CReP treated
with 50µM Rotenone.
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Figure 26. CReP Expression in Mammalian Hep3B Cells Treated for 4 hours with ER Stress
Inducers. HEK293T cells were transfected with 1.5µg of cloned pcDNA3.1 with CReP and
treated for 4 hours with ER stress inducers. Lane 1: 250kDa ladder. Lane 2: WT CReP treated
with DMSO. Lane 3: 11A CReP treated with DMSO. Lane 4: 31A CReP treated with DMSO.
Lane 5: WT CReP treated with 50µM Rotenone. Lane 6: 11A CReP treated with 50µM
Rotenone. Lane 7: 11A CReP treated with 50µM Rotenone. Lane 8: WT CReP treated with
20µM Bleomycin. Lane 9: 11A CReP treated with 20µM Bleomycin. Lane 10: 31A CReP
treated with 20µM Bleomycin.

Further experimentation needs to be carried out to determine if the changes in molecular
weight seen in the prior experiments is valid. For these experiments, endogenous CReP can be
isolated by using Sepharose beads tagged with CReP antibody and allow for the pull-down and
purification of the CReP protein. After cleaning up this purification, this sample can be prepared
for mass spectrometry to determine if there are indeed changes in the molecular weight of CReP
when treated with ER stress inducers.

